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Constituents of emerging concern (CECs) have accumulated in drinking water 
source supply over the past decades. Although there are currently no established 
treatment standards, CECs should be of concern to the public and the environment. The 
goal of this study was to better understand the fate of CECs in a conventional activated 
sludge (CAS) wastewater treatment plant. To achieve this goal, two objectives were 
identified: (i) evaluate unit operational changes that increase removal efficiency of 
CECs and (ii) evaluate the efficacy of advanced treatment options. This research 
measured 98 CECs throughout a CAS facility. Subsequent to these analyses, a 
stochastic fate model was developed to quantitatively understand CECs’ fate through 
CAS processes. Results of the model indicate that primary clarifiers and secondary plug 
flow reactors (PFRs) significantly reduced CEC concentrations. CEC removal 
percentages in the primary clarifiers range from 9.1% (triclosan) to 79.8% (atenolol). 
PFR removal percentages range from <0% (meprobamate, gemfibrozil, and sucralose) 
to >98.6% (caffeine) and overall plant removal percentages range from 6.7% 
(gemfibrozil) to >98.9% (caffeine). Even with relatively low removal percentages, some 
influent and effluent CEC concentrations are well below monitoring trigger thresholds, 
which indicate safe drinking-water concentrations. Furthermore, because wastage rate 
controls the mean cell residence time, wastage rate is the most influential operational 
control on the effect on CEC removal. In conclusion, by providing operational and 
advanced treatment analysis, this modeling approach can help determine key factors in 
CEC removal from CAS facilities. 
 
1 
Chapter 1: Introduction 
Constituents of emerging concern (CECs) are chemicals that are being detected 
in water that were not previously detected or that are being detected at different levels 
than anticipated (EPA, 2014). CECs can include household chemicals (detergents, 
deodorizers), pharmaceuticals (hormones, beta blockers, antibiotics), and personal care 
products (antacids, caffeine). Because wastewater treatment plant (WWTP) process 
units are not optimized to remove CECs, these compounds may be discharged into the 
environment. Accumulation of CECs is a concern for ecosystems, as well as for human 
consumption via indirect or direct water reuse (Githinji et al., 2010). Several researchers 
(Bernhard et al., 2006; Clara et al., 2004; Clara at al., 2005; Kimura et al., 2004; Kimura 
et al., 2007; Radjenović et al., 2007; Wang et al., 2013) have studied the fate of CECs in 
WWTPs and examined various treatment processes. These treatment processes can 
include conventional activated sludge (CAS), membrane bioreactors (MBR), reverse 
osmosis (RO), nanofiltration (NF), aerobic and anaerobic digestion, and advanced 
oxidation processes (AOPs), including ultraviolet irradiation (UV), hydrogen peroxide 
(H2O2), and ozone disinfection. Of these treatment processes, CAS is one of the most 
commonly used. CAS removes CECs using two key removal mechanisms: biological 
degradation and adsorption to biosolids (Lee et al., 2009). Because removal efficiencies 
are a function of hydraulic retention time (HRT), solids retention time (SRT), and the 
physical, chemical and biological characteristics of the wastewater (Johnson et al., 
2005; Monteith et al., 2008), CEC concentration levels in wastewater vary greatly and 
can be difficult to predict. However, various researchers (Lee et al., 2009; Luo et al., 
2014; and Miège et al., 2008) have compiled CEC removal efficiency data (Table 2-1) 
2 
from 153 studies of conventional WWTPs (WWTPs utilizing CAS). As stated above, 
the primary conclusion among these studies is that CEC removal efficiencies depend 
upon several factors. However, some common characteristics or commonalities can be 
observed. For instance, CEC removal percentage increases with increased HRT and 
SRT (Clara et al., 2005a; Johnson et al., 2005; Monteith et al., 2008). Furthermore, 
based on the Arrhenius theorem, as temperature increases, CEC removal rates increase 
(Clara at al., 2004; Monteith et al., 2008). Modeling CECs in a specific WWTP would 
allow for the evaluation of operational changes to increase CEC removal efficiencies. 
These changes could include modifications to sludge recycling rates, HRTs, SRTs, 
biomass makeup and recycling, disinfection processes, and temperature. Finally, 
because modeling allows for a detailed analysis of the process performance, it provides 
an indication of what unit processes can be optimized or expanded. 
This research will determine key CECs in the City of Norman Water 
Reclamation Facility (NWRF) and will monitor these CECs in the influent and effluent 
of major processes within the NWRF. Furthermore, it will develop a stochastic fate 
model of the NWRF, integrating CECs into the model. More generally, it will help to 
quantitatively understand CECs through WWTPs and will be a template for further 




Chapter 2: Literature Review and Background 
2.1 Removal Efficiencies of CECs in Conventional WWTPs 
There is extensive research on CEC removal efficiencies (Table 2-1) in CAS 
WWTPs (Lee et al., 2009; Luo et al., 2014; Miège et al., 2008). Although some 
compounds show similar removal efficiencies from the three studies, other compounds 
show a wide range due to varying HRT, SRT, and wastewater and biomass makeup. 
From these studies, it is clear that removal efficiencies are specific to WWTP 
characteristics and results are quite variable. For instance, removals of acetaminophen, 
estrone, and ibuprofen do not vary greatly across the three studies. Meanwhile, 
compounds like bezafibrate, diethyltoluamide (DEET), gemfibrozil, sulfamethoxazole, 
and tonalide all differ from study to study. Furthermore, Luo et al. (2014) found a large 
range of removal percentages for some compounds. As mentioned, these ranges in 
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Osachoff et al. (2014), using synthetic wastewater containing pharmaceutical 
and personal care products, studied removal efficiencies (Table 2-2) in a bench-scale 
CAS process. The synthetic wastewater contained: caffeine, di(2-ethylhexyl)phthalate, 
estrone, 17α-ethinylestradiol, ibuprofen, naproxen, 4-nonlyphenol, tonalide, 
triclocarbon, and triclosan.  
Table 2-2: Laboratory Tested Conventional Activated Sludge Removal of 








Caffeine 45,579 250 99.5 
Di(2-ethylhexyl)phthalate 40,609 15,565 61.7 
Estrone 70 20 71.6 
17α-Ethinylestradiol 6.0 1.5 75.1 
Ibuprofen 27,600 8667 68.6 
Naproxen 15,000 9000 40.0 
4-Nonylphenol 31,000 125 99.6 
Tonalide 1017 25 97.5 
Triclocarbon 3000 73 97.6 
Triclosan 3000 250 91.7 
 
Di(2-ethylhexyl)phthalate, estrone, 17α-Ethinylestradiol, and ibuprofen were 
only moderately removed while naproxen was moderately conserved in the treatment 
process. Because of their lower removal efficiencies, di(2-ethylhexyl)phthalate, estrone, 
17α-Ethinylestradiol, ibuprofen, and naproxen should be noted as potential key CECs 
for modeling. 
 
2.2 Removal Efficiencies of CECs in MBRs and Advanced Treatment Processes 
In addition to compiling data for CAS, Lee et al. (2009) accumulated and 
analyzed CEC removal efficiencies from MBR, NF, RO, granular activated carbon 
(GAC), and powdered activated carbon (PAC). MBRs use CAS but replace the 
secondary clarifier with membrane filtration. NF, RO, GAC, and PAC are considered 
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advanced treatment (AT) processes and are typically used after WWTP processes like 
CAS or MBRs. NF and RO use membranes to filter contaminants from the passing 
wastewater. GAC uses adsorption in a fixed-bed process. In contrast, PAC is a 
suspended media in the water. All of these advanced treatment (AT) processes 
performed better than CAS in removing CECs (Lee et al., 2009). Table 2-3 shows 
removal efficiency characteristics of several AT processes. 











Removal Below 50% 
Percent of Compounds 
with Removal Above 90% 
or Below Detection Limit 
MBR 49 14 33 39 
CAS 33 9 64 27 
NF 57 n.d. 17 82 
RO 60 n.d. 12 82 
GAC 29 0 0 97 
PAC 71 6 31 41 
n.d. not determined 
Although GAC does have high removal efficiencies, according to Lee et al. 
(2009), several studies found that competitive adsorption can decrease removal 
efficiency and the operating life of the filter, especially when organic matter is present 
(Lee et al., 2009). Competitive adsorption is a process in which compounds compete for 
adsorption sites on cells. It is controlled by the maximum heat and energy required for 
adsorption (Gun’ko, 2007). Because of this phenomenon, hydrophilic and large-
molecular weight compounds may not be removed as well because they do not have 
accessibility to the inner pores of carbon in the filter (Lee et al., 2009). 
GAC can be combined with a biologically active layer in what is referred to as 
biological activated carbon (BAC). Reungoat et al. (2011) found that BAC had removal 
efficiencies of greater than 90% for 21 pharmaceuticals analyzed. Although adsorption 
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might have some role in these high removal percentages, biodegradation was found to 
be the primary removal mechanism (Reungoat et al., 2011). 
 
2.3 Operational Effects on CEC Removal Efficiencies  
Several researchers have examined the effects of WWTP operational parameters 
on CEC removal efficiencies (Johnson et al., 2005; Clara et al., 2005a; Lishman et al., 
2006). Johnson et al. (2005) studied the impact that HRT, SRT, biological HRT (HRT 
in the biological treatment zones), and temperature have on the estrogenic hormone 
estrone (E1). In analyzing seventeen WWTPs throughout Europe; Johnson et al. (2005) 
found that E1 removal rates (Figure 2-1) increased as HRT and SRT increased, 
especially biological HRT. It should be noted that the Pearson product-moment 
correlation coefficient (R
2
), obtained from a linear regression of each parameter, is 
relatively low. Consequently, there exists a general downward trend (Figure 2-1) from 
these data but resulting relationships should not be viewed as exact tendencies. It is 
important to note that the influent concentrations were estimated from excretion rates, 
population data, and flow, resulting in artificially higher E1 levels at low retention times 













=0.16), and (c) SRT (R
2
=0.28) (Johnson et al., 2005) 
 
Clara et al. (2005a) analyzed E1, 17β-estradiol (E2), 17α-ethinylestradiol (EE2), 
caffeine, and bezafibrate using bench-scale experiments with varying SRTs along with 
































































































for which the compound removal is maximized) for E1 and E2 was between 5 and 10 
days, with almost complete removal of these two compounds occurring after 10 days. 
EE2, meanwhile, did not show consistent removal rates. Even for similar SRTs, 
removal rates varied quite drastically (Clara et al., 2005a). Both E1 and E2 are natural 
estrogens, while EE2 is a pharmaceutical. This could be the reason for variation in 
removal through WWTPs. Both caffeine and bezafibrate had removal rates of more than 
95%. Furthermore, critical SRTs for caffeine and bezafibrate were found to be 5 and 10 
days, respectively (Clara et al., 2005a). 
Lishman et al. (2006) analyzed CECs in twelve different WWTPs along the 
Thames River in Canada. Seven of the twelve WWTPs consisted of only CAS while 
two of the twelve had CAS and media filtration. The remaining treatment plants used 
lagoon treatment processes. Among other CECs, Lishman et al. (2006) evaluated 
concentrations of gemfibrozil, diclofenac, celestolide, phantolide, galaxolide, and 
tonalide. As expected, gemfibrozil, diclofenac, and celestolide (ADBI) all had increased 
removal efficiencies as SRT increased. Traseolide (ATII), galaxolide (HHCB), and 
tonalide (AHTN), meanwhile, did not show these tendencies. For a SRT between 3 and 
5 days, no correlation was discovered. However, for SRT over 5 days, ATII removal 
efficiency increased with increasing SRT. Meanwhile, for HHCB and AHTN, removal 
efficiency seemed to slightly decrease with increased SRT. This can likely be attributed 
to the lack of data for larger SRT ranges. In many cases, effluent concentrations of these 
compounds were below detectable levels (BDL), making it difficult to correlate any 
patterns in removal efficiency. Other CECs evaluated, including ibuprofen and 
naproxen, had high (~95%) removal efficiencies but also varied with increased SRT. 
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For these two compounds, Lishman et al. (2006) noted that removal efficiency 
tendencies could not be found with treatment configurations or operational parameters. 
 
2.4 Removal Mechanisms 
CECs are removed from wastewater by biodegradation and adsorption to 
biosolids (Lee et al., 2009; Ghalajkhani, 2013). Although volatilization could be 
considered, it is negligible for most CECs due to their low octanol-water partitioning 
coefficients (log KOW) and Henry coefficients (KH) (Clara et al., 2005b). CEC 
compounds can partition between the neutral (HA) and ionized form (A
-
) which impact 
the rate of sorption or biodegradation (Figure 2-2). 
 
Figure 2-2: Ionized CEC Sorption and Biodegradation Diagram 
 
As presented in Figure 2-2, sorption and biodegradation of ionized CECs must 
be accounted for in the neutral and ionized forms. In contrast, neutral compounds (not 
shown) only require sorption and biodegradation rates for the neutral form. However, 
for this research, it is unknown whether each CEC is in the ionized or neutral form. 
Therefore, sorption and biodegradation rates are considered to be equal for both forms. 
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2.4.1 Sorption 
Sorption consists of both adsorption from liquid to a solid and desorption, or a 
solid to liquid phase. The amount of a compound sorbed onto biomass can be modeled 
by the compound’s partitioning coefficient, Kd (Equation 2.1) (Joss et al., 2006). Note: 
Ms is mass associated with substrate, Mss is mass associated with suspended solids, Mx 








 Kd is the compound partitioning coefficient (L
3
/Mss) 
X is the sorbed compound concentration (Ms/L
3
) 
 S is the concentration of the compound (Ms/L
3
), and 




 Rearranged, the amount of sorbed compound is: 
𝑋 = 𝐾𝑑 × 𝑉𝑆𝑆 × 𝑆 Equation 2.2 
 
 As shown, sorption is not modeled using a kinetic expression. However, Ternes 
et al., (2004) found that equilibrium was reached after just 0.5 hours in a batch reactor. 
Because the clarifiers and the PFR at the NWRF have HRTs greater than 0.5 hours, 
sorption is assumed to reach equilibrium. 
The desorption rate (rdes (Ms/L
3
)) does not depend on the influent concentration 
of the compound. Instead, it is dependent on the concentration of the compound on the 
12 
biomass. Therefore, rdes (Equation 2.3) is equal to Kdes multiplied by the concentration 
of the compound sorbed onto the biomass (X) (Ghalajkhani, 2013). 
𝑟𝑑𝑒𝑠 = 𝐾𝑑𝑒𝑠𝑋 Equation 2.3 
The rate of desorption is assumed to be slower than adsorption. Therefore, kdes is 
assumed to be 0.1 d
-1
, meaning that desorption is assumed to happen at 10% of the rate 
that adsorption takes place (Ghalajkhani, 2013). 
Githinji et al. (2010) analyzed ciprofloxacin and amoxicillin, determining 
sorption rates and biodegradation tendencies. The experimental sorption rates 
determined are presented in Figure 2-3. 
 
Figure 2-3: Sorption Coefficients of Amoxicillin and Ciprofloxacin under varying 
pH (Githinji et al., 2010) 
 
The key conclusion developed from this study is that ciprofloxacin had higher 
adsorption rates than amoxicillin and amoxicillin portioning coefficients decreased with 




















pH of 5.5 and decreased as pH increased after that point. Because amoxicillin has a 
higher pKa value than ciprofloxacin, it dissociates in water at a higher rate. Therefore, 
amoxicillin has less electrostatic attraction and sorbs to solids at a lower rate than 
ciprofloxacin (Githinji et al., 2010). At higher pH, amoxicillin and ciprofloxacin 
compounds are more negatively charged, resulting in less electrostatic attraction with 
solids in the system. Consequently, the sorption potential of these compounds decreases 
at higher pH values (Githinji et al., 2010). This should be considered when selecting 
sorption coefficients for CECs. Furthermore, neither antibiotic significantly degraded 
within 48 hours, indicating the importance of an adsorption removal mechanism 
(Githinji et al., 2010). 
 
2.4.2 Biodegradation 
Lee et al. (2012) used a Monod biokinetic expression to model triclosan 
degradation in wastewater. The same concept can be used for other CECs with the 
alteration of half saturation constants (K) and maximum specific rate of substrate 
utilization (q̂). The Monod expression, in terms of substrate utilization (rut), is presented 







rut is the rate of substrate utilization (Ms/L
3
 · T) 
q̂ is the maximum specific rate of substrate utilization (Ms/Mx · T) 
S is the concentration of the rate-limiting substrate (Ms/L
3
) 








It should be noted that this is a pseudo-order utilization rate, resulting in two 
boundary conditions. At low concentrations of substrate (S<<K, which is the case for 
CECs), the net specific growth rate (µ) can be modeled as a first-order rate (Figure 2-4). 
 
 
Figure 2-4: Net Specific Growth Rate vs. Substrate Concentration 
 
Based on the observation that the CEC exists at low concentrations in the waste 
stream, it can be assumed that first-order rates apply to CEC biodegradation. Therefore, 




𝑋𝑎 − 𝑏𝑋𝑎 
Equation 2.5 
where  
rnet is the net rate of active biomass growth (Mx/L
3
 · T) 
Y is the true yield (Mx/Ms), and 
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b is the endogenous-decay coefficient (1/T) 
 Because half-saturation coefficients are not well documented, a simpler 
modeling method for biodegradation is to use biodegradation constants. As noted, 
because first-order rates apply, Equation 2.6 can be used in determining removal due to 
biodegradation (Joss et al., 2006; Tran et al., 2015). 
𝑟𝑢𝑡 = −𝑘𝑏𝑖𝑜𝑋𝑎𝑆 Equation 2.6 
where 
  kbio is the biodegradation constant (L
3
/Mx · T) 
  
 Similar to Equation 2.5, rnet can then be described using Equation 2.7. 
𝑟𝑛𝑒𝑡 = 𝑌𝑘𝑏𝑖𝑜𝑋𝑎𝑆 − 𝑏𝑋𝑎 Equation 2.7 
 
 However, because CEC concentrations are small compared to biomass 
concentrations, their effect on biomass can be considered negligible. For this reason and 
to simplify modeling, the net rate of biomass growth was modeled as the negative rate 
of CEC utilization (Equation 2.6). 
 
2.5 Modeling CECs in GPS-X 
Based on a thorough literature review, much of the CEC research focus has been 
centered around bench/pilot scale studies; with little attention aimed at treatment 
process optimization. However, Ghalajkhani (2013); Monteith et al. (2008) and Schraa 
et al. (2006), have provided a framework for using a standard process model (GPS-X, 
Hydromantis, Ontario Canada) to study CEC fate in municipal wastewater systems. 
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CECs were integrated into the models using the Model Developer (MD) tool. MD 
allows for the creation of new models using a matrix format. New models allow for the 
addition of rates and kinetic and stoichiometric relationships, as well as other model 
parameters (Hydromantis, 2014). 
Ghalajkhani (2013) used GPS-X to model the fate of xenobiotic organic 
compounds (XOCs). XOCs stem from personal care products, pharmaceuticals, 
excreted hormones, and household and industrial chemicals. Using data from existing 
research for calibration (Collado et al., 2012; Zhao et al., 2007), the following sorption 
and biotransformation constants were determined for ibuprofen (Table 2-4) and 
bisphenol-A (Table 2-5). Kd-HA is the solid-liquid partitioning coefficient for the neutral 
form of an iodized compound; Kd-A- is the solid-liquid partitioning coefficient for the 
ionized form of an ionized compound; Kd-N is the solid-liquid partitioning coefficient 
for a neutral compound; Kbio-HA is the aerobic biodegradation rate constant for the 
neutral form of an ionized compound; and Kbio-N is the aerobic biodegradation rate 
constant for a neutral compound (Ghalajkhani, 2013). 
Table 2-4: Calibrated Ibuprofen Partitioning and Biotransformation Coefficients 
(Ghalajkhani, 2013) 
Parameter Lower Bound Upper Bound 
Optimal Value ± Standard 
Error 
Kd-HA (L/mg biomass) 1.59E-05 7.53E-04 3.23E-4±6.02E-5 
Kbio-HA (L/mg biomass/d) 0.0681 0.2877 0.1943±0.10 
Kd-A- (L/mg biomass) 1.32E-06 6.26E-05 1.96E-5±5.72E-6 
Note: The biodegradation rate for the ionized form of an ionized compound, Kbio-A-, was not provided. 
Table 2-5: Calibrated Bisphenol-A Partitioning and Biotransformation 
Coefficients (Ghalajkhani, 2013) 
Parameter Lower Bound Upper Bound 
Optimal Value ± Standard 
Error 
Kd-N (L/mg biomass) 5.75E-05 7.19E-04 4.935E-4±5.3E-5 
Kbio-N (L/mg biomass/d) 0.0047 0.0697 0.0502±7.9E-3 
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Rate constants similar to those shown in Table 2-4 and Table 2-5 will be needed 
in order to model other CECs. Once CECs are selected for modeling, biodegradation 
constants and partitioning coefficients will be estimated from literature values. 
Monteith et al. (2008) developed equations for sorption and biotransformation 
processes (including parent and daughter cells) of the estrogenic hormones E1, E2, and 
synthetic estrogen EE2. These equations were developed via literature review and the 
results were compared with actual field data in order to calibrate the model. Table 2-6 
presents the initial and calibrated physical and chemical properties that Monteith et al. 
(2008) used in modeling. The calibrated initial properties were adjusted after comparing 
the modeled results to literature data (Monteith et al., 2008). 
Table 2-6: Initial Physical and Chemical Properties of Three Estrogenic Hormones 
(Monteith et al., 2008) 
Property E1 E2 EE2 
Molecular weight (Daltons) 270.4 272.4 296.4 
Density (g/cm
3
) 1.23 1.2 1.2 
Henry's coefficient (Lliq/Lgas) 1.54E-08 1.47E-10 3.21E-10 
Log Kow 3.13 4.01 3.67 
Initial Aerobic kbio (m
3
/g VSS-d) 0.205 0.429 0.00097 












Calibrated Aerobic kbio (m
3
/g VSS-d) 0.0216 0.024 0.00097 
Calibrated Anoxic kbio (m
3
/g VSS-d)  0.007  
Calibrated Anaerobic kbio (m
3
/g VSS-d)  0.013  
 
After calibration, the model was analyzed with varying temperature, SRT, HRT, 
and total suspended solids (TSS) concentrations. Under 9 to 11°C, sorption impacts 
removal rates more than biotransformation. At these low temperatures, 
biotransformation kinetics decrease, and the compounds are removed primarily from 
sorption to biosolids. However, above 9 to 11 °C, it was found that biotransformation 
plays a larger role on the removal of the hormones (Monteith et al., 2008). Generally, as 
temperature increases, so does the removal of the estrogenic hormones (Figure 2-5).  
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This is likely due to the Arrhenius equation, which states that kinetic constants increase 
as temperature increases. 
 
Figure 2-5: Effluent Estrogenic Hormone Concentrations vs. Varying 
Temperature (Monteith et al., 2008) 
 
Monteith et al. (2008) also studied isothermal SRT impact on hormone 
concentrations. At 20°C, no significant changes in effluent concentration were observed 
after an aerobic SRT of 5 days (Figure 2-6). However, at a constant temperature of 
10°C, E2 concentrations decreased as aerobic SRT increased (Figure 2-7). E1 and EE2 
decreased, but not substantially. 
 
Figure 2-6: Effluent Estrogenic Hormone Concentrations vs. Aerobic SRT, 20°C 




Figure 2-7: Effluent Estrogenic Hormone Concentrations vs. Aerobic SRT, 10°C 
(Monteith et al., 2008) 
 
The effects of aeration HRT were examined on the estrogenic hormone levels. 
As expected, increased aeration HRT resulted in decreased levels of total hormone 
concentrations. In this case, removal efficiency plateaued after a HRT of about five 
days. 
Monteith et al. (2008) also examined the effect that TSS concentrations have on 
the hormone concentrations. Because the majority of the estrogenic hormones in the 
primary and final effluents were free and not bound, TSS did not have a large effect on 
the hormone concentrations (Figure 2-8). 
 
Figure 2-8: Effluent Estrogenic Hormone Concentrations vs. TSS Concentration 
(Monteith et al., 2008) 
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Schraa et al. (2006) modeled pharmaceutical wastewater through a WWTP that 
contained fungal and bacterial integrated fixed-film activated sludge (IFAS). Schraa et 
al. (2006) used the mantis model, a modified activated sludge model (ASM), because of 
the following modifications from ASM: temperature dependence of kinetic parameters; 
growth limitation due to low ammonia conditions; simultaneous nitrification and 
denitrification; and updated kinetic parameters. After calibration, modeling was used to 
analyze the WWTP with treatment processes offline, varying temperatures, and lower 
air flowrates in the reactors (Schraa et al., 2006). 
 
2.6 NWRF Characteristics 
The NWRF has an average flowrate of about 10 MGD (from 2012 and 2013 
data). Utilizing CAS, it consists of primary and secondary clarification, a plug flow 
reactor (PFR) aeration basin, and anaerobic digesters. The current unit processes and 
sizes are shown in Table 2-7. Figure 2-9 and Figure 2-10 display a labeled aerial view 
and a process flow diagram with sampling locations, respectively. 
Table 2-7: Current NWRF Layout 
2015 NWRF Layout 
Bar Screen 
2 Grit Chambers 
2 Primary Clarifiers @ 0.200 MG each 
2 Primary Clarifiers @ 0.288 MG each 
3 Chamber Aeration Basin @ 0.990 MG per chamber 
2 Secondary Clarifiers @ 0.676 MG each 
2 Secondary Clarifiers @ 1.33 MG each 
4 Gravity Thickeners @ 0.019 MG each 
4 Anaerobic Digesters @ 0.633 MG each 
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Figure 2-10: NWRF Process Flow Diagram 
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Chapter 3: Hypothesis and Objectives 
It is hypothesized that utilizing MBRs will be more effective than operational 
changes to the CAS process at removing CECs in the NWRF. From literature, MBRs 
typically have higher removal efficiencies than CAS (Lee et al., 2009). MBRs are 
desirable because of their small space requirements, their capability of replacing 
secondary clarifiers (EPA, 2007), and their ability to be placed inside or outside an 
existing CAS aeration basin (Lee et al., 2009). Furthermore, because MBRs are able to 
maintain higher concentrations of biomass, less volume is needed in CAS aeration 
basins (EPA, 2007). Finally, MBRs provide additional pathogen barriers, providing 
increased removal that may be desirable for water reuse applications (Alan Plummer 
Associates, Incorporated, 2015). 
 
3.1 Objective 1 
The first objective of this research is to evaluate the impact of operational 
parameters (HRT, SRT, sludge recycling, disinfection adjustments, etc.) on the removal 
efficiency of CECs. To achieve this objective the following tasks have been identified: 
(i) develop a model of the current NWRF layout (base model), (ii) calibrate the base 
model, (iii) validate the base model, (iv) integrate CECs using MD to develop an 




3.2 Objective 2 
The second objective is to evaluate AT options (such as MBR, NF, RO, UV 
disinfection, GAC, and BAC) that help to increase removal efficiency of CECs. This 
objective will use the advanced model to further the understanding of the fate through 
AT processes.  
 
3.3 Goal 
The goal of this research is to develop a stochastic model to optimize CEC 
















Chapter 4: Methodology 
The scope of this research included: reviewing literature regarding the fate of 
CECs through WWTPs; analyzing water quality data of the influent and effluent of 
major treatment processes from the NWRF; determining rate constants and biological 
and physiochemical properties of CECs to be modeled; developing a base model in 
GPS-X of the current layout of the NWRF; calibrating and validating the base model; 
developing an enhanced model that uses MD to integrate CECs into the base model; 
calibrating and validating the enhanced model; developing an expanded model that 
expands the enhanced model to include the future layout of the NWRF; and developing 
an advanced model to evaluate operational changes and AT options to increase removal 
efficiencies of CECs. 
 
4.1 Outline 
The first step of this research was to complete a thorough literature review. 
Common CECs in wastewater and typical removal efficiencies were determined. Due to 
the vast numbers of CECs that could be used and due to budget limitations, indicator 
CECs were modeled. In order to select CECs for modeling, CECs with similar 
physiochemical and biological characteristics and function were grouped together. After 
grouping, indicator CECs were used to represent the group. Although validators did not 
always behave the same as indicators, most validators performed the same as its 
indicator CEC through at least one treatment process (Table 5-4). Therefore, indicators 
from a resource document by Alan Plummer Associates, Incorporated (2015) were used 
for modeling in order to better understand entire groups of CECs. The sampling 
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locations at the NWRF were the preliminary treatment effluent, primary clarifier 
effluent, aeration basin effluent, secondary (final) clarifier effluent, primary anaerobic 
digester effluent, and secondary anaerobic digester effluent. After selection of CECs, 
literature values were again used to determine biodegradation constants and partitioning 
coefficients of CEC (Table 4-2). 
 
4.2 Base Model Development, Calibration, and Validation 
During CEC literature review and selection, the base NWRF model was 
developed. Due to limitations of the GPS-X model, only half of the plant was modeled. 
Because the NWRF has four primary, four secondary clarifiers, four thickeners, and 
four anaerobic digesters (as of 2015), only two of each of these treatment processes 
were modeled. The PFR’s volume, meanwhile, was divided by two and all three 
chambers were kept for modeling purposes. Furthermore, because only one-half of the 
plant was modeled, the influent flowrate was divided by two. Because the flow was 
halved, one of each size of clarifier (both primary and secondary) was used for 
modeling. In the model, flow was further split to account for the size of each clarifier. 
These splits, along with the current NWRF and modeled physical parameters are shown 







Table 4-1: NWRF and Base Model Physical Parameters 
2015 NWRF Layout Base and Enhanced Model Layout 
Bar Screen Bar Screen 
2 Grit Chambers 1 Grit Chamber 
2 Primary Clarifiers @ 0.200 MG each 
2 Primary Clarifiers @ 0.288 MG each 
1 Primary Clarifier @ 0.200 MG (40% of flow) 
1 Primary Clarifier @ 0.288 MG (60% of flow) 
3 Chamber Aeration Basin @ 0.990 MG per 
chamber 
3 Chamber Aeration Basin @ 0.495 MG per 
chamber 
2 Secondary Clarifiers @ 0.676 MG each 
2 Secondary Clarifiers @ 1.33 MG each 
1 Secondary Clarifier @ 0.676 MG (34% of flow) 
1 Secondary Clarifier @ 1.33 MG (66% of flow) 
4 Gravity Thickeners @ 0.019 MG each 2 Gravity Thickeners @ 0.019 MG each 
4 Anaerobic Digesters @ 0.633 MG each 2 Anaerobic Digesters @ 0.633 MG each 
 
Splitting the plant allowed for the model to be calibrated using the data provided 
by the NWRF. The data provided by the NWRF included typical WWTP parameters, 
including: temperature, carbonaceous biological oxygen demand (cBOD), ammonia, 
TSS, dissolved oxygen (DO), alkalinity, and pH from 2012 and 2013 (Appendix A: 
NWRF Typical Wastewater Parameters). 
Calibration involved adjustment of model parameters so that modeled effluent 
concentration levels of cBOD, ammonia, and TSS closely match actual levels found 
from sampling over the entire year of 2013. The model was then validated by 
confirming the effluent concentrations of cBOD, ammonia, and TSS from 2012. 
Validation confirms the calibration of the system, verifying that modeled effluent 
concentrations match data from the NWRF. With validation, the effluent data should 
closely match the levels from the model. 
 
4.3 Enhanced Model Development, Calibration, and Validation 
The next step was to integrate CECs into the base model using the MD tool. The 
MD tool allows custom libraries to be created within GPS-X. MD uses a matrix format 
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and can be used to add new contaminant parameters and alter rate equations and 
constants, making it possible to precisely model varying wastewater parameters. In this 
case, CEC parameters were added to the base model, creating the enhanced model. 
During this process, the five sections of the MD tool were populated. These sections 
are: GPS-X Libraries, Stoichiometric Matrix, Model Kinetics, Model Parameters, and 
Composite Variables. The GPS-X Libraries section contains the existing state variables 
and composite variable stoichiometry parameters. State variables are used by GPS-X to 
perform mass balance calculations. They include the various forms of COD, nitrogen, 
phosphorus, and other wastewater parameters. Composite variables are calculated from 
the state variables and include: TSS, volatile suspended solids (VSS), total cBOD5, total 
COD, total Kjeldahl nitrogen (TKN), TN, total phosphorus, and total carbon. The 
Stoichiometric Matrix contains state variables in columns and kinetic processes in rows, 
showing the stoichiometric relationship between the state variables and the rate 
processes within the model. It allows the addition of process rates such as the sorption, 
desorption, and biodegradation of CECs. The Model Kinetics section has the kinetic 
equations used in the model. It incorporated Equation 2.2 to Equation 2.6 to quantify 
CEC sorption, desorption, biodegradation, and biomass production from CEC 
biodegradation, respectively. The Model Parameters tab contains state variables, 
stoichiometric parameters, and kinetic parameters. This section allows for the entry of 
new rate constants and is where desorption constants, partitioning coefficients, and 
biodegradation constants were entered into the model. The Model Parameters section 
also allows for the application of Arrhenius coefficients, making it possible to analyze 
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temperature’s effect on CEC removal. Finally, the Composite Variables tab shows fixed 
composite variable stoichiometry (Hydromantis, 2014). 
After CECs were integrated, the enhanced model was calibrated and validated in 
a similar way to the base model. In this case, indicator CECs from certain groups (Alan 
Plummer Associates, Incorporated, 2015) were selected for calibration (Table 4-2), 
while other CECs from the same group were used for validation (Table 4-3). Along 
with compiling a list of indicator CECs, Alan Plummer Associates (2015) also compiled 
monitoring trigger thresholds (MTTs) for each CEC. These MTTs assume a 150-pound 
person that consumes 2 liters of water per day to estimate acceptable concentrations of 















Table 4-2: Indicator CEC Sorption and Biodegradation Constants 
Indicator 
CEC 





























































































































* Note: Validation CECs that are similar to the indicator CEC do not exist in the sampling suite. 
┼  
Note: Several studies have shown zero removal of CEC (Luo et al., 2014; Meyer and Bester, 2004) 





















Table 4-3: Validation CEC Sorption and Biodegradation Constants 
Class Validation CEC Kd (L/kg) kbio (L/g – d) 































































* Note: Validation CECs that are similar to the indicator CEC do not exist in the sampling suite. 
┼  Note: Several studies have shown zero removal of CEC (Luo et al., 2014; Meyer and Bester, 2004) 
 
Note: Concentrations were below MRL 
^ Literature data not found. Values are assumed to be similar to caffeine constants. 
 
a
 Urase and Kikuta, 2005 
b
 Ternes et al., 2004 
c
 Joss et al., 2006 
d
 Jones et al., 2002 
e
 Radjenović et al., 2009 
f
 Carballa et al., 2008 
g




 Hyland, 2014 
i
 Okuda et al., 2009 
j
 Joss et al., 2004 
k 
Stevens-Garmon et al., 2011 
l
 Wick et al., 2009 
m
 Tran et al., 2015 
n
 Blair et al., 2015 
 
CECs have varying biodegradability based on whether the treatment process is 
aerobic, anoxic, and anaerobic. At the NWRF, both sets of digesters are currently 
anaerobic. However, the digester modules in GPS-X are not compatible with the MD 
tool. The digesters have large variability in removal percentages (Table 5-2). However, 
a lack of modeling could result in incorrect concentrations in the digester effluents. 
Table 4-2 and Table 4-3 served as a preliminary list of expected CECs to model. 
However, some of the CECs listed were below the method reporting limit (MRL) (as 
noted in the tables). After removal percentages were determined for each CEC (Table 
5-2), each pair of indicator and validation CECs was confirmed to have similar removal 
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percentages in the primary clarifiers, PFR, or both unit processes. In contrast to base 
model calibration, instead of adjusting just model parameters, CEC rate constants and 
coefficients were adjusted as part of the calibration process. 
 
4.4 Expanded and Advanced Models 
After the enhanced model was calibrated and validated, the expanded model was 
developed. The expanded model utilized the enhanced model but was modified with 
currently proposed (and ongoing) plant expansion treatment processes. This included 
adjustments to certain treatment processes, as well as a volume expansion of the 
aeration basin and final clarifiers. The current plant expansion also includes the addition 
of a UV disinfection process. With the initial expanded model developed, multiple 
scenarios were analyzed to determine the NWRF performance on CEC removal 
efficiency with varying conditions. Next, in the advanced model, additional AT 
processes were integrated and analyzed. These processes were simulated to determine 
their effects on CEC removal efficiency. 
 
4.5 Model Limitations 
A portion of the expansion at the NWRF is the addition of UV disinfection. 
Although GPS-X has a disinfection treatment process, UV is not an option. 
Furthermore, in order to use a treatment process to model CECs, the unit must be 
compatible with the MD tool. Although the MD tool is compatible with primarily 
suspended and attached growth processes, other treatment processes are available. 
Below, the options given for model generation are shown (Figure 4-1). Since UV was 
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not included as an option in GPS-X, it was not included in the expanded or advanced 
models. 
 
















Chapter 5: Results and Discussion 
5.1 Sampling and Analysis 
Sampling was completed on January 27, 2016. In order to monitor the 
wastewater as it passed through the plant, samples were taken at different times 
throughout the day based on the units’ hydraulic retention time (HRT). It was assumed 
that the data would be more representative of each treatment processes’ removal 
capability if HRT was taken into consideration. Table 5-1 displays each unit’s estimated 
HRT along with the time of sampling for each. A few items should be addressed 
regarding the sampling times and locations: 
 The first sampling point was the preliminary treatment effluent. It was 
assumed that there were no changes in CEC concentrations between the 
plant influent and preliminary treatment effluent. Therefore, the 
preliminary effluent only had to be sampled at an early enough time to 
be able to sample the rest of the plant on the same day.  
 The primary and secondary digesters have HRTs of multiple days. 
Because time was of importance, these treatment processes were 
sampled at 9:30 AM, without taking HRT into consideration. 
 The NWRF does not have a sampling location for the PFR effluent. 
Therefore, the PFR effluent was actually taken towards the bottom of 





Table 5-1: Treatment Process Sampling Times 
Treatment Process HRT (hours) Sampling Time 
Preliminary Treatment Effluent N/A
 
6:37 AM 
Primary Clarifier Effluent 3 9:35 AM 
PFR Effluent 6 3:40 PM 
Secondary Clarifier Effluent 3 6:37 PM 
Primary Digester Effluent N/A* 9:30 AM 
Secondary Digester Effluent N/A* 9:30 AM
 
   * HRT is several days and was not considered during sampling due to time constraints. 
  
Eurofins Eaton Analytical performed the analysis of 98 CECs. However, only 
38 (Table 5-2) of these were above the MRL in one or more of the treatment processes 
(Appendix B: CECs (and MRLs) Analyzed). Furthermore, each indicator CEC is 
significantly lower than its MTT concentration. Several CECs increase in concentration 
as they move through the plant (Table 5-2). If more samples could have been collected 
(during other days and even seasons), it is likely that fewer CECs would have negative 
removal percentages. However, it is worth noting that there would likely still be CECs 
with negative removal percentages. This is due to the fact that biodegraded products can 
convert back to the parent compound during treatment processes (Jelić et al., 2012). For 
instance, theobromine could have converted back to caffeine. Due to the high percent 
removal of both compounds, though, this was likely not the case for theobromine. 
Negative removal percentages can also be attributed to the desorbing of CECs in a unit 
operation. Previously sorbed CECs can desorb, causing an increase in concentration. 
Furthermore, instrumental errors can result in small negative removal percentages 























Compound (MTT in ng/L) ng/L ng/L ng/L ng/L ng/L ng/L 
1,7-Dimethylxanthine 4200 3500 14 13 18 18 
4-nonylphenol - semi quantitative 1200 <100 460 510 400 570 
4-tert-Octylphenol 950 380 330 350 210 390 
Acesulfame-K 26000 22000 1400 1400 7400 7200 
Acetaminophen 26000 12000 <500 <500 <500 <500 
Albuterol 17 <5 <5 <5 <5 <5 
Amoxicillin 15000 15000 16000 18000 12000 11000 
Atenolol (4,000) 990 200 100 90 96 <5 
Atrazine <5 <5 <5 <5 63 55 
Azithromycin 290 270 270 200 140 180 
Butalbital 9.4 10 10 11 <5 <5 
Caffeine 45000 36000 <500 <500 <500 <500 
Carbamazepine 88 110 110 110 140 200 
Cotinine 940 710 48 57 240 770 
DEET (200,000) 290 220 <100 <100 140 300 
Diltiazem 42 34 27 24 <5 <5 
Estrone (E1) 12 <5 <5 <5 <5 <5 
Ethylparaben 200 <20 <20 <20 <20 <20 
Gemfibrozil (800,000) 1500 1200 1500 1400 1100 1800 
Iohexol 61000 44000 36000 37000 5500 370 
Iopromide (750,000) 
 
410 16 16 28 31 
Lidocaine 320 <5 290 290 270 <5 
Lopressor 1400 3000 960 1200 1500 1800 
Meprobamate (200,000) 51 34 44 45 42 29 
Methylparaben 100 <20 <20 <20 <20 <20 
Metolachlor 11 11 6.9 10 81 74 
Naproxen 140 170 19 <10 32 <10 
Primidone 
 
88 100 94 69 52 
Propylparaben 670 180 10 <5 24 77 
Salicylic Acid 750 430 <100 <100 <100 <100 
Simazine 140 150 170 160 7.7 <5 
Sucralose (150,000,000) 23000 4900 22000 19000 26000 23000 
Sulfamethoxazole 990 1100 900 1000 32 <5 
TCPP 160 <100 180 160 410 <100 
Theobromine 8200 6800 <100 <100 <100 <100 
Theophylline 12000 9200 <200 <200 <200 <200 
Triclosan (2,100,000) 11 <10 <10 <10 <10 <10 
Trimethoprim 260 310 380 440 <50 <50 
 
In the next step, CECs were arranged and graphed according to overall plant 
removal percentage (Figure 5-1 to Figure 5-6). CECs that have removal percentages 
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greater than 90% generally are significantly (95% confidence interval (CI) of 67.2 to 
100% for PFR removal percentage) removed in the PFR. CECs that have removal 
percentages between 50 and 90% are removed more in the primary clarifiers than in the 
PFR. CECs with percentage removals lower than 50% do not show any general trends. 
Several of these compounds increase in concentration during the treatment process, 
which could be due to biodegraded compound converting back to their parent 
compounds, desorption of previously sorbed compounds, or sampling/instrumental 
errors. 
 
Figure 5-1: NWRF CEC Concentrations with Removal Percentage Greater than 
95% 
* Concentrations were below the MRL in the plant effluent. 
**Concentrations were below the MRL in the PFR and plant effluents. 







































Figure 5-2: NWRF CEC Concentrations with Removal Percentage between 90 and 
95% 
* Concentrations were below the MRL in the plant effluent. 
**Concentrations were below the MRL in the PFR and plant effluents. 
***Concentrations were below the MRL in the primary clarifiers, PFR, and plant effluents. 
 
 
Figure 5-3: NWRF CEC Concentrations with Removal Percentage between 70 and 
90% 
* Concentrations were below the MRL in the plant effluent. 
**Concentrations were below the MRL in the PFR and plant effluents. 



































































Figure 5-4: NWRF CEC Concentrations with Removal Percentage between 50 and 
70% 
* Concentrations were below the MRL in the plant effluent. 
**Concentrations were below the MRL in the PFR and plant effluents. 
***Concentrations were below the MRL in the primary clarifiers, PFR, and plant effluents. 
 
 
Figure 5-5: NWRF CEC Concentrations with Removal Percentage between 30 and 
50% 
* Concentrations were below the MRL in the plant effluent. 
**Concentrations were below the MRL in the PFR and plant effluents. 






































































Figure 5-6: NWRF CEC Concentrations with Removal Percentage between 0 and 
30% 
* Concentrations were below the MRL in the plant effluent. 
**Concentrations were below the MRL in the PFR and plant effluents. 
***Concentrations were below the MRL in the primary clarifiers, PFR, and plant effluents. 
 
Averages, standard deviations, and 95% CIs were calculated for each range of 
CECs (Table 5-3). Several removal percentage groups have only one or two CECs in 
the group. Because of this, some averages, standard deviations, and 95% CIs have large 
ranges. For CECs with concentrations below the MRL, the MRL concentrations were 













































Table 5-3: Statistical Analysis of NWRF CEC Removal Percentages 
  









































38.4 54.3 - 
70 to 80 1 70.6 - - 70.6 - - 0.0 - - 
60 to 70 2 64.3 1.7 
61.9 - 
66.7 
42.1 25.4 6.9 - 77.3 33.9 29.3 
0 - 
74.5 
50 to 60 2 57.9 0.6 
57.1 - 
58.7 
75.0 23.6 42.3 - 100 - - - 
40 to 50 1 42.9 - - 19.0 - - 20.6 - - 
30 to 40 2 35.2 5.9 
27.0 - 
43.4 
17.4 14.8 0 - 37.9 9.1 12.9 - 
20 to 30 0 - - - - - - - - - 
10 to 20 3 14.5 2.8 
10.6 - 
18.4 
- - - - - - 
>0 to 10 4 8.6 1.3 
7.3 - 
9.9 
31.9 45.1 - - - - 
Note: Negative removal percentages are not included in average, standard deviation, or 95% CI          
calculations. 
 
To narrow the scope of the research, indicator and validator CECs (Table 4-2) 
were isolated from other CECs and plotted in the same manner as above (Figure 5-7 to 
Figure 5-9). The total plant removal percentages for each CEC are shown in parentheses 
in the legend. Almost every CEC that is removed greater than 30% in the overall plant 
shows moderate removal percentage in the primary and secondary clarifiers and CECs 
with removal percentages greater than 90% are considerably removed in the PFR. This 
is expected as VSS and Xa levels are about six and twenty times larger in the PFR than 
in the clarifiers, respectively (Figure 5-17). 
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Figure 5-9: Indicator and Validator CECs with Removal Percentage between 0 
and 30% 
 
The removal percentages of each indicator CEC and its validation CEC were 
compared (Table 5-4). CECs with large negative removal percentages are not listed and 
were not included in the scope of this research. Furthermore, for CECs that have large 
negative removal percentages in any of the treatment processes (meprobamate, 
gemfibrozil, and sucralose); only the unit that had a positive removal percentage was 
calibrated in the model. As mentioned, these negative removal percentages can be 
attributed to a lack of multiple data sets or CECs converting back to their parent 
compounds (Jelić et al., 2012) or desorption of the compound (Verlicchi et al., 2012). 
Due to the complexity that this phenomenon would add to the model, these CECs were 
instead calibrated for the treatment process that showed positive removal percentages. 
Due to budgetary constraints, CEC sampling was only done on one day (January 





































adsorption constants were adjusted) using the average influent data for the month of 
January, 2016 (Table 5-5). 
Table 5-4: Removal Percentages of Indicator and Validator CECs 










Compound Class % % % % % 
Meprobamate Anti-Anxiety Indicator 33.3 -29.4 -2.3 11.8 31.0 




Atenolol Beta Blocker Indicator 79.8 50.0 10.0 90.9 100.0 




Gemfibrozil Lipid Regulator Indicator 20.0 -25.0 6.7 6.7 -63.6 
DEET Repellant Indicator 24.1 >54.5 
 
>65.5 -114.3 




Theobromine Caffeine Degradate Validator 17.1 >98.5  >98.8  
Sucralose Sugar Substitute Indicator 78.7 
-
349.0 
13.6 17.4 11.5 
Acesulfame-K Sugar Substitute Validator 15.4 93.6 0.0 94.6 2.7 
Iopromide 






X-Ray Contrast Agent 
Validator 
27.9 18.2 -2.8 39.3 93.3 
 
Table 5-5: Average Influent Conditions for January 2016 
Influent Parameters 
Temperature 17.1°C 
Influent Flow (split) 4.985 MGD 
pH 7.44 
TSS 161 mg/L 
cBOD5 263 mg/L 
Ammonia 20.7 mg/L 
DO 0.6 mg/L 
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5.2 Base Model 
Preliminary steps of this research included the development, calibration, and 
validation of the base model. As mentioned, due to the size of the NWRF, the plant had 
to be divided in half (Table 4-1 and Figure 5-10).  
46 
 
Figure 5-10: GPS-X Base Model Layout 
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In the GPS-X model, the influent passes through a bar screen and grit chamber 
before it is split to the two primary clarifiers (60% to the 0.288 million gallon (MG) 
clarifier and 40% to the 0.200 MG clarifier). The flow then combines into the PFR 
aeration basin, where it goes through three separate chambers in series. Next, the flow is 
split again to the secondary clarifiers (34% to the 0.676 MG clarifier and 66% to the 
1.33 MG clarifier). The settled material from the primary clarifiers and some of the 
settled biomass, or waste activated sludge (WAS), from the secondary clarifiers are 
combined and split again (50%-50%) to the sludge thickeners. The remaining settled 
biomass, or return activated sludge (RAS), is recycled to the influent of the PFR. The 
secondary clarifier effluent is combined and released from the WWTP. From the 
thickeners, the thickened sludge goes through the two anaerobic digesters in series. The 
residual water from the thickeners and digesters is brought back to the front of the plant 
upstream of the belt screen. 
 
5.2.1 Base Model Calibration 
After the base model was developed, it was calibrated using daily NWRF 
cBOD, TSS, and ammonia data for the entire year of 2013. To analyze the accuracy of 
the model, measured and modeled concentrations of these three constituents, along with 
the 30-day moving average of the measured data, were plotted together (Figure 5-11 to 
Figure 5-13). The residual sum of squares (RSS) (Equation 5.1) and explained sum of 
squares (ESS) (Equation 5.1) were calculated for each constituent over the entire year 
and are displayed in the figures. 
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  n is the number of number of observations 
  yi is the measured constituent concentration at day i, and 
  ŷi is the modeled constituent concentration at day i. 







  ȳ is the mean of the measured constituent concentration. 
 
 
























Measured cBOD Modeled cBOD 30-Day Measured Moving Average
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Figure 5-13: 2013 Measured and Modeled Effluent Ammonia (RSS=40.3 and 
ESS=29.7) 
 
Modeled TSS is higher than measured TSS in the warmer months (Figure 5-12). 
Conversely, in 2012 data (the validator year), modeled TSS is lower than measured TSS 













































Measured Ammonia Modeled Ammonia 30-Day Measured Moving Average
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in either the calibrated year or validated year showing accurate results, but not both. 
The same can be said for adjusting Arrhenius coefficients for cBOD and ammonia. 
During calibration, because of a lack of data, several RAS and secondary 
clarifier WAS rates were analyzed. As expected, both parameters proved to have a 
significant influence on cBOD and TSS concentrations. After analyzing various RAS 
and WAS flows and slightly adjusting other model parameters (influent BOD and 
nutrient ratios, PFR ratios and stoichiometry, and settling characteristics), a RAS of 
70% and secondary clarifier WAS of 4% of the total influent flow were found to result 
in the lowest combined RSS (cBOD=1145.9; TSS=1724.4; and ammonia=40.3) for all 
three constituents in the calibration year. 
 
5.2.2 Base Model Validation 
After adjustments were made for the base model calibration, the same 
parameters were used for base model validation. Although measured data from the 
validation year (2012) varied significantly, the modeled data generally provided 
reasonable results (RSS values: cBOD=1747.7; TSS=961.4; and ammonia=69.4) 
(Figure 5-14 to Figure 5-16). As mentioned, adjusting settling characteristics could 
result in the calibration year or validation year being more accurate, but not both. The 
settling characteristics used herein resulted in the lowest RSS for TSS between both 
calibration and validation years. Similarly, adjusting Arrhenius coefficients proved that 
the model could be calibrated to reduce RSS values for the calibration or validation 
year, but not both. Additionally, as cBOD is a function of RAS and secondary clarifier 
WAS rates, both could be adjusted to result in cBOD modeled data that lowered RSS. 
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In fact, calibration revealed that RAS and secondary clarifier WAS had the largest 
effect on effluent results. However, with no data to support changing these rates, 70% 
(RAS) and 4% (secondary clarifier WAS) were assumed. This research, as shown in 
Sections 5.4.1 and 5.4.4, analyzed plant efficiency under various RAS and WAS rates. 
 















































Figure 5-16: 2012 Measured and Modeled Effluent Ammonia (RSS=69.4 and 
ESS=40.4) 
 
5.3 Enhanced Model 
After base model calibration and validation, the MD tool was used to 
incorporate CECs and biodegradation and adsorption reactions and constants into the 
model. Because it allows for customizable state variables, the Carbon, Nitrogen, 
Phosphorus, Custom Components library (cnpiplib) was used. By coding some of the 
text files associated with this library, CEC names were entered into the model. GPS-X 




























Measured Ammonia Modeled Ammonia 30-Day Measured Moving Average
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szb Soluble atenolol xzb Particulate atenolol 
szd Soluble meprobamate xzd Particulate meprobamate 
sze Soluble triclosan xze Particulate triclosan 
szf Soluble gemfibrozil xzf Particulate gemfibrozil 
szg Soluble DEET xzg Particulate DEET 
szh Soluble caffeine xzh Particulate caffeine 
szi Soluble theobromine xzi Particulate theobromine 
szj Soluble sucralose xzj Particulate sucralose 
szk Soluble acesulfame-K xzk Particulate acesulfame-K 
szl Soluble iopromide xzl Particulate iopromide 
szm Soluble iohexol xzm Particulate iohexol 
 
Most pharmaceuticals have solubility concentrations on the order of mg/L, while 
concentrations in wastewater are on the order of ng/L (Shraim et al., 2012). Therefore, 
plant influent CEC concentrations (before adsorption takes place) are assumed to be in 
the soluble form. During adsorption, the CECs move from soluble to particulate matter 
and, as shown in Section 5.6, are considerably removed during final sedimentation. 
Unless specifically noted as “particulate”, all references to CECs in this research are 
meant as soluble CECs. 
The next step in the model developer tool was to set up and populate the 
Stoichiometry Matrix (Appendix C: Stoichiometry Matrix). Then, Equation 2.2, 
Equation 2.3, and Equation 2.6 were modified to be entered into the Kinetic Equations 
section (Appendix D: Kinetic Equations and Equation 5.3 to Equation 5.5). For this 
case, the equations below are shown for E1 (sza). The three equations were used for 
every indicator and validator CEC. It should be noted that only state variables can be 
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used in the Kinetic Equations second. In GPS-X, VSS is a composite variable. 
Therefore, Equation 5.3 had to be modified to include only state variables. 
𝑋 = 𝑘𝑑𝐸1 × 𝑠𝑧𝑎 × 𝑉𝑆𝑆 
= 𝑘𝑑𝐸1 × 𝑠𝑧𝑎 ×





  X is the sorbed CEC concentration (g/m
3
) 
kdE1 is the E1 partitioning coefficient (m
3
/g) 
  sza is the soluble E1 concentration (g/m
3
) 
  VSS is the volatile suspended solids concentration (g/m
3
) 
  icv is the particulate COD to VSS ratio 
  xs is the slowly biodegradable substrate concentration (g/m
3
) 
  xbh is the active heterotrophic biomass concentration (g/m
3
) 
  xba is the active autotrophic biomass concentration (g/m
3
) 
  xsto is the internal cell storage product concentration (g/m
3
) 




  xbt is the polyhydroxyalkanoates concentration (g/m
3
) 
  xgly is the stored glycogen concentration (g/m
3
) 
  xi is the particulate inert organic material concentration (g/m
3
), and 







𝑟𝑑𝑒𝑠 = 𝑘𝑑𝑒𝑠 × 𝑥𝑧𝑎 Equation 5.4 
where 
  rdes is the rate of adsorption of particulate E1 (m
3
/g · d) 
kdes is the desorption coefficient (1/d), and 




𝑟𝑏𝑖𝑜 = −𝑘𝑏𝑖𝑜𝐸1 × 𝑠𝑧𝑎 × 𝑥𝑏ℎ Equation 5.5 
where 
  rbio is the rate of biodegradation of the CEC (g/m
3 
· d) 
  kbioE1 is the E1 biodegradation constant (g/m
3 
· d) 
  sza is the soluble E1 concentration (g/m
3
), and 




Next, because the biodegradation and sorption constants are not defined in the 
model, they were added using the Kinetic Parameters section (Appendix E: Kinetic 
Parameters). Here, sorption and biodegradation constants were defined and assigned 
values within the model. 
During the enhanced model development, it was discovered that the PFR was 
able to handle the modified model fairly easily. However, when the same model was 
developed for the primary clarifiers, the model slowed significantly. For the secondary 
clarifiers, the model became nonresponsive. Due to the low removal percentages in the 
secondary clarifiers, (no indicator or validator CEC was removed more than 13.6% 
(Table 5-4)) they were not modeled in this research. 
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5.3.1 Enhanced Model Calibration and Validation 
During enhanced model calibration, biodegradation was found to have a larger 
effect on CEC removal than adsorption. This is evidenced by the general trend of CEC 
biodegradation constants being larger than their partitioning constants (Table 4-2 and 
Table 4-3). Although VSS is greater than the active heterotrophic biomass (Xa) 
concentration (Figure 5-17) in each treatment process, it is not a large enough difference 
to offset the differences in biodegradation and adsorption constants. 
 
Figure 5-17: Modeled VSS and Xa Concentrations during Sampling 
 
 To calibrate the enhanced model, the biodegradation and adsorption constants 
were varied until modeled CEC concentrations matched measured concentrations. 
When possible, the constants were kept as close to literature values as possible. 
However, in some cases, this was not possible, as literature values resulted in effluent 


































Table 5-7: Calibrated Biodegradation and Adsorption Constants 
 
kbio (L/g-d) Kd (L/kg) 
 
Literature Modeled Literature Modeled 
Meprobamate - 0 316.2-631.0 790.0 (Prim. Clar.) 
Triclosan 1.2-3.6 1.2 1905-9550 1905.0 
Atenolol 0.69-2.2 4.2 0.21-152 300.0 
E1 162±25 162.0 170-362 170.0 
Gemfibrozil 6.4-9.6 0.0 (Prim. Clar.) 10.0-1106 400.0 (Prim. Clar.) 
DEET - 1.5 58.9-1258.9 100.0 
Caffeine 39.6-50.9 











Sucralose 0.003-0.009 .0065 (Prim. Clar.) 66.6-1084.6 540.0 (Prim. Clar.)     
Acesulfame-K 0.0448-0.0594 










Iohexol 1.8-2.4 0.8 - 0 
┼ 
The calibrated constant was determined using removal efficiency rather than concentration. 
 
 As noted, PFR biodegradation constants for caffeine, theobromine, acesulfame-
K, and iopromide were determined using PFR removal percentages rather than the 
actual concentration. Caffeine, theobromine, and acesulfame-K were removed more in 
the PFR than in the primary clarifiers while the influent data for iopromide was reported 
to be below MRL. Without developing an entirely new model for treatment processes 
with different biodegradation constants, there was no way to use different values for the 
primary clarifiers and PFR. Therefore, for caffeine, theobromine, and acesulfame-K, the 
model was first analyzed using primary clarifier constants. Then, kbio was adjusted in a 
separate analysis until the modeled removal percentages closely matched the measured 
removal percentages. For iopromide, only one analysis was used to match the modeled 
PFR removal percentage with the measured PFR removal percentage. 
Due to negative removal percentages in the PFR, biodegradation and adsorption 
constants for meprobamate, gemfibrozil, and sucralose were only determined for the 
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primary clarifiers. Throughout the remainder of the analyses, these three compounds are 
only analyzed in the primary clarifier. 
Both E1 and triclosan had PFR, secondary clarifier, and effluent concentrations 
below the MRL. Therefore, the minimum literature biodegradation and adsorption 
constants that resulted in modeled effluent concentrations below the MRL were used.  
The only calibration and validation CECs that perform the same throughout the 
NWRF are caffeine and theobromine. Because theobromine is a product of caffeine 
degradation (Asano et al., 1993), this is expected. Although sucralose and acesulfame-K 
are removed similarly in the primary clarifiers, acesulfame-K is more highly 
biodegraded in the PFR than sucralose. The partitioning coefficients for iohexol and 
iopromide are both well above each CEC’s literature value. Iohexol, though, has a 
higher biodegradation constant than iopromide. From the constants in Table 5-7, 
concentrations of each CEC were plotted for each treatment process (Figure 5-18 to 
Figure 5-29). 
 































































































































































































Figure 5-23: Enhanced Model DEET Concentrations under Sampling Conditions 
 
 



























































































































































































































































Figure 5-29: Enhanced Model Iohexol Concentrations under Sampling Conditions 
 
 
 Most CECs are removed predominantly by biodegradation. Generally, CECs are 
removed more in the PFR than in the primary clarifiers. Furthermore, CECs with higher 
removal percentages are more affected by biodegradation than by adsorption. While 
biodegradation and adsorption averages are similar in the primary clarifier, 
biodegradation becomes the dominant removal mechanism in the PFR (Table 5-8). The 
percent removed by biodegradation is calculated by dividing the concentration removed 
of a given CEC due to biodegradation by the total amount the CEC is removed (from 
biodegradation and adsorption) in each treatment process. The percent adsorption is the 








































Table 5-8: Enhanced Model Biodegradation vs. Adsorption during Sampling 
CEC Treatment Process 
Percent of Total Removal 
Biodegradation Adsorption Total 
Meprobamate* 
Primary Clarifier 0.0% 100.0% 100.0% 
PFR 0.0% 100.0% 100.0% 
Triclosan 
Primary Clarifier 34.4% 65.6% 100.0% 
PFR 69.5% 30.5% 100.0% 
Atenolol 
Primary Clarifier 90.3% 9.7% 100.0% 
PFR 98.9% 1.1% 100.0% 
E1 
Primary Clarifier 100.0% 0.0% 100.0% 
PFR 100.0% 0.0% 100.0% 
Gemfibrozil* 
Primary Clarifier 0.4% 99.6% 100.0% 
PFR 0.3% 99.7% 100.0% 
DEET 
Primary Clarifier 87.8% 12.2% 100.0% 
PFR 96.2% 3.8% 100.0% 
Caffeine 
Primary Clarifier 51.3% 48.7% 100.0% 
PFR 100.0% 0.0% 100.0% 
Theobromine 
Primary Clarifier 49.9% 50.1% 100.0% 
PFR 100.0% 0.0% 100.0% 
Sucralose* 
Primary Clarifier 0.9% 99.1% 100.0% 
PFR 1.9% 98.1% 100.0% 
Acesulfame-K 
Primary Clarifier 16.1% 83.9% 100.0% 
PFR 100.0% 0.0% 100.0% 
Iopromide 
Primary Clarifier - - - 
PFR 100.0% 0.0% 100.0% 
Iohexol 
Primary Clarifier 100.0% 0.0% 100.0% 
PFR 100.0% 0.0% 100.0% 
Average 
Primary Clarifier 48.3% 51.7% 100.0% 
PFR 72.2% 27.8% 100.0% 
* Modeled concentrations were used because measured concentrations showed negative removal 
percentages. 
 
5.4 Expanded Model 
After calibration of the enhanced model, the NWRF expansion was incorporated 
into the model, creating the expanded model. The only changes in the model from the 
current NWRF layout (Table 4-1) are the addition of an identical PFR (0.495 MG per 
chamber) and a secondary clarifier (1.33 MG). Because the PFR volume will increase 
by 100% and the final clarifier by 66%, an adjusted flowrate that is 75% greater than 
the most recent flowrate data is used. In keeping the other parameters constant (Table 
66 
5-5), CEC removal percentages for the expanded and enhanced model were compared 
(Figure 5-30 to Figure 5-41). 
As mentioned, as part of the plant expansion, the NWRF will also incorporate 
UV disinfection as one of the last treatment processes. Unfortunately, GPS-X is unable 
to model UV disinfection. Like other oxidants, UV removal is largely dependent on 
concentration-time (or intensity-time in the case of UV) (Lee et al., 2009). In two 
studies, CEC removal percentage ranged from 1 to 90%, depending on the intensity-
time provided by the UV lamps and the pH (Canonica et al., 2008; Kim et al., 2009). 
 
 
Figure 5-30: Expanded Model Meprobamate Concentrations under Sampling 





































Figure 5-31: Expanded Model Meprobamate Concentrations under Sampling 
Conditions (Modified Flowrate) 
 
 
Figure 5-32: Expanded Model Atenolol Concentrations under Sampling 










































































Figure 5-34: Expanded Model Gemfibrozil Concentrations under Sampling 












































































Figure 5-36: Expanded Model Caffeine Concentrations under Sampling 



















































































Figure 5-37: Expanded Model Theobromine Concentrations under Sampling 
Conditions (Modified Flowrate) 
 
 
Figure 5-38: Expanded Model Sucralose Concentrations under Sampling 
















































































Figure 5-39: Expanded Model Acesulfame-K Concentrations under Sampling 
Conditions (Modified Flowrate) 
 
 
Figure 5-40: Expanded Model Iopromide Concentrations under Sampling 















































































Figure 5-41: Expanded Model Iohexol Concentrations under Sampling Conditions 
(Modified Flowrate) 
 
 The expanded model has higher CEC concentrations in the primary clarifier 
effluent (Figure 5-30 to Figure 5-41). Because the expanded plant does not include an 
additional primary clarifier, it is likely that CEC concentrations are higher due to the 
increased flow rate per clarifier. In some cases, the additional PFR is able to 
compensate for the lack of an additional primary clarifier. Triclosan, atenolol, E1, 
DEET, caffeine, theobromine, iopromide, and iohexol all show similar, if not lower, 
concentrations in the expanded PFRs when compared to the enhanced PFR. When using 
70% RAS for both the enhanced and expanded models, the primary clarifiers in both 
have similar VSS and Xa concentrations (Figure 5-42). In the PFR, expanded model 
VSS and Xa concentrations are noticeably larger. This implies that the rate of 
biodegradation and the amount of sorbed compound are larger in the expanded model 





































Figure 5-42: Expanded vs. Enhanced Model VSS and Xa Concentrations 
 
 Biodegradation and adsorption were compared in the primary clarifiers and the 
PFRs for the expanded model (Table 5-9). As with the enhanced model (Table 5-8), 
removal due to biodegradation and adsorption is roughly equal in the primary clarifier. 
Biodegradation in the PFRs becomes slightly higher in the expanded model because of 
the additional PFR. Because biodegradation is the primary removal mechanism (Table 
5-8) in the PFRs, this is expected. VSS is over three times larger than Xa in the primary 
clarifiers (Figure 5-42). However, because biodegradation rates are typically larger than 
adsorption rates (Table 5-7), removal from biodegradation and adsorption are almost 
equal in the primary clarifiers. In the PFRs, VSS and Xa concentrations are closer 










































Table 5-9: Expanded Model Biodegradation vs. Adsorption in the Expanded 
Model 
CEC Treatment Process 
Percent of Total Removal 
Biodegradation Adsorption Total 
Meprobamate* 
Primary Clarifier 0.1% 99.9% 100.0% 
PFR 0.1% 99.9% 100.0% 
Triclosan 
Primary Clarifier 33.2% 66.8% 100.0% 
PFR 76.7% 23.3% 100.0% 
Atenolol 
Primary Clarifier 90.4% 9.6% 100.0% 
PFR 100.0% 0.0% 100.0% 
E1 
Primary Clarifier 100.0% 0.0% 100.0% 
PFR 100.0% 0.0% 100.0% 
Gemfibrozil* 
Primary Clarifier 0.0% 100.0% 100.0% 
PFR 0.0% 100.0% 100.0% 
DEET 
Primary Clarifier 90.5% 9.5% 100.0% 
PFR 100.0% 0.0% 100.0% 
Caffeine 
Primary Clarifier 56.1% 43.9% 100.0% 
PFR 100.0% 0.0% 100.0% 
Theobromine 
Primary Clarifier 54.9% 45.1% 100.0% 
PFR 100.0% 0.0% 100.0% 
Sucralose* 
Primary Clarifier 1.2% 98.8% 100.0% 
PFR 2.4% 97.6% 100.0% 
Acesulfame-K 
Primary Clarifier 19.8% 80.2% 100.0% 
PFR 100.0% 0.0% 100.0% 
Iopromide 
Primary Clarifier - - - 
PFR 100.0% 0.0% 100.0% 
Iohexol 
Primary Clarifier 100.0% 0.0% 100.0% 
PFR 100.0% 0.0% 100.0% 
Average 
Primary Clarifier 49.7% 50.3% 100.0% 
PFR 73.3% 26.7% 100.0% 
* Modeled concentrations were used because measured concentrations showed negative removal 
percentages. 
 
After comparing the enhanced and expanded model with parameters from the 
day of sampling, the expanded model was then extrapolated and examined over an 
entire year (Figure 5-43 to Figure 5-54). With the exception of flow (which is 75% 
higher in the expanded model), influent data from 2013 is used in the analysis of the 
daily expanded model. With the exception of meprobamate, gemfibrozil, and sucralose, 




Figure 5-43: Expanded Extrapolated Meprobamate Concentrations 
* Due to negative removal percentage in the PFR, the CEC was only calibrated in the primary clarifiers. 
 
Figure 5-44: Expanded Extrapolated Triclosan Concentrations 



































































Figure 5-45: Expanded Extrapolated Atenolol Concentrations 
 
 
Figure 5-46: Expanded Extrapolated E1 Concentrations 







































































































Figure 5-47: Expanded Extrapolated Gemfibrozil Concentrations 
* Due to negative removal percentage in the PFR, the CEC was only calibrated in the primary clarifiers. 
 
 
Figure 5-48: Expanded Extrapolated DEET Concentrations 

































































Figure 5-49: Expanded Extrapolated Caffeine Concentrations 
* Measured effluent concentration was below the MRL. 
 
 
Figure 5-50: Expanded Extrapolated Theobromine Concentrations 








































































































































Figure 5-51: Expanded Extrapolated Sucralose Concentrations 
* Due to negative removal percentage in the PFR, the CEC was only calibrated in the primary clarifiers. 
 
 



































































































Figure 5-53: Expanded Extrapolated Iopromide Concentrations 
 
 
Figure 5-54: Expanded Extrapolated Iohexol Concentrations 
 
 Modeled CECs have similar removal patterns throughout the entire year of 
modeling. Most CECs reach their maximum concentration sometime in the middle of 
the year and decrease around 230 days. It should be noted that this assumes the same 


































































































biodegradation and adsorption constants were only found in the primary clarifier for 
meprobamate, gemfibrozil, and sucralose, these CECs have higher removals in the 
expanded model than in the measured data (each CEC had negative plant removal 
percentages). Although they have varying removal percentages, each CEC decreases in 
concentration around a time of 230 days. This is likely due to increasing VSS and Xa 
concentrations at this time (Figure 5-55 to Figure 5-56), as well as an increase in water 
temperature (Figure 5-57). 
 


























































Figure 5-56: Expanded Model Primary Clarifier and PFR Xa Concentrations 
 
 
Figure 5-57: Daily Water Temperature 
 
5.4.1 RAS Analysis 
After analyzing the expanded plant with the estimated RAS from base model 
calibration (70%), VSS, Xa, and the CECs were analyzed with varying RAS rates. In 







































































and comes from the settled solids in the secondary clarifiers. Because RAS does not 
require physical alteration of the plant, it is a reasonable change that can be made to the 
plant. While primary clarifier VSS and Xa decrease with increasing RAS, PFR 
concentrations increase (Figure 5-58 to Figure 5-59). Because RAS is pumped from the 
settled solids area in the secondary clarifiers to the influent of the PFR, concentrations 
in the PFR increase as the RAS flow increases. Both VSS and Xa have a greater rate of 
change at lower RAS rates. In the primary clarifier, both decrease at approximately 
equal rates of change. In the PFRs, VSS increases at a greater rate than Xa as RAS 
increases. As RAS approaches 100%, it has less effect on concentration. As RAS 
increases, plant effluent VSS increases and Xa decreases (Figure 5-60). 
 































Figure 5-59: PFR VSS and Xa with Varying RAS 
 
 
Figure 5-60: Plant Effluent VSS and Xa with Varying RAS 
 
The decrease in VSS and Xa in the primary clarifiers results in a higher 
concentration of CECs as RAS increases (Figure 5-61 to Figure 5-63). Because VSS 
























































5-64 to Figure 5-66). Due to the small differences in removal percentage, the CECs 
have been grouped in ranges. 
 
Figure 5-61: Primary Clarifier CEC Removal with Varying RAS (0-30% Removal) 
 
 















































































Figure 5-63: Primary Clarifier CEC Removal with Varying RAS (70-100% 
Removal) 
 
Each CEC has a lower removal percentage in the primary clarifiers as RAS 
increases (Figure 5-61 to Figure 5-63). Acesulfame-K, gemfibrozil, caffeine, 
theobromine, iohexol, sucralose, and meprobamate do not have significant removal 
changes after about 50% RAS. DEET, atenolol, triclosan, and iopromide have a greater 
































Figure 5-64: PFR CEC Removal with Varying RAS (20-40% Removal) 
 
 












































































Figure 5-66: PFR CEC Removal with Varying RAS (80-100% Removal) 
 
In the PFRs, iohexol has the greatest increase in removal percentage (~8%) of 
any CEC modeled (Figure 5-64). Triclosan, atenolol, iopromide, acesulfame-K, E1, 
caffeine, and theobromine do not show any considerable removal change above a RAS 
of about 30%. However, some of these CECs (triclosan, atenolol, iopromide, and 
acesulfame-K), display gradually smaller removal percentages as RAS approaches 
100%. 
 Ultimately, due to the decreased removal percentage in the primary clarifiers 
and the increased removal percentages in the PFR, RAS proved to have a small effect 
on the total plant CEC removal. CECs that are equally removed in the primary clarifiers 
and the PFRs (atenolol and triclosan) tend to decrease in removal percentage as RAS 
increases. CECs with reliance on the PFR for removal (iohexol, DEET, and acesulfame-
K) behave the opposite, as RAS increased, the CEC’s removal percent also increased 











































Figure 5-67: Plant CEC Removal with Varying RAS (10-50% Removal) 
 
 
Figure 5-68: Plant CEC Removal with Varying RAS (60-100% Removal) 
 
 To further analyze RAS effects, other plant effluent parameters were compared. 
Variability in RAS has a larger effect on TSS than it does cBOD or TKN (Figure 5-69). 































































Similar to VSS, TSS in the RAS stream causes an increase in concentration in both the 
PFR and the plant effluent. 
 
Figure 5-69: Plant Effluent TSS, cBOD, and TKN with Varying RAS 
 
5.4.2 Primary Clarifier Volume Analysis 
Next, primary clarifier volume’s effect on CEC removal was examined. The 
analysis was completed for primary clarifier volume ranging from 57% to 200% of the 
size of the current primary clarifiers. In general, primary clarifier has a larger effect on 
CEC removal than RAS. First, the removal percentages of the primary clarifiers were 
analyzed. Although primary clarifier, PFR, and plant effluent VSS and Xa decrease with 
increasing primary clarifier volume (Figure 5-70 to Figure 5-72), CEC removal 
percentage in the primary clarifier increase due to the increased HRT (Figure 5-73). 
































































































Figure 5-72: Effluent VSS and Xa with Varying Primary Clarifier Volume 
 
 
Figure 5-73: Primary Clarifier CEC Removal with Varying Primary Clarifier 
Volume 
 
Each modeled CEC decreases in primary clarifier effluent concentration as 
primary clarifier volume increases (Figure 5-73). As expected, CECs that are more 


















































































influenced by primary clarifier volume. However, even CECs that are initially removed 
primarily by the PFR (Figure 5-7) experience at least some increase in removal 
percentage as volume increases. Next, the PFR was analyzed under varying primary 
clarifier volumes (Figure 5-74 to Figure 5-75). 
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As primary clarifier volume increases, the removal percentages of iohexol, 
DEET, atenolol, iopromide, acesulfame-K, theobromine, and caffeine slightly decrease. 
Meanwhile, triclosan and DEET’s removal percentages both decrease by about 10%. In 
general, as the volume of the primary clarifier increases, the percent removal observed 
in the PFR decreases. This can be attributed to two reasons. First, there are lower 
concentrations of VSS and Xa in the PFR, as they are being more removed in the 
primary clarifiers (Figure 5-71). Second, because the primary clarifiers are also 
removing higher percentages of CECs, there is a lower concentration entering the PFR 
(Figure 5-73). Biodegradation and adsorption are first-order with respect to CEC 
concentration and Xa and VSS concentrations, respectively. Because of this 
relationship, removal rates decrease. Although the PFR removal decreases, because of 
the increased primary clarifier removal, the overall plant removal for most CECs 
increases with increased primary clarifier volume (Figure 5-76 to Figure 5-77).  
 




































Figure 5-77: Plant CEC Removal with Varying Primary Clarifier Volume (67-
100% Removal) 
 
Although the difference is small, as the primary clarifier volume increases, CEC 
removal increases. Interestingly, though, the removal percentage for each CEC 
increases at approximately the same rate. This indicates that, while biodegradation and 
adsorption constants are important factors in determining the removal percentage of 
each CEC, primary clarifier HRT helps to improve removal, regardless of the 
biodegradation and adsorption rates. However, as primary clarifier volume is doubled, 
most CEC removal percentages increase only by 3 to 4%. 
 
5.4.3 Primary Clarifier WAS Analysis 
The next operational modification analyzed was the primary clarifier waste 
activated sludge (WAS) (defined as waste flowrate divided by plant flowrate) rates. 






































Analysis indicated that primary clarifier WAS has minimal effect on VSS, Xa, and thus, 
on CEC removal (Figure 5-78 to Figure 5-80). 
 
 
Figure 5-78: Primary Clarifier VSS and Xa with Varying Primary Clarifier WAS 
 
 































































Figure 5-80: Effluent VSS and Xa with Varying Primary Clarifier WAS 
 
Due to the small decrease of VSS and Xa in the primary clarifiers and PFRs, 
CEC removal percentages slightly decrease with increased WAS. Due to the small 
removal percentage decrease in the primary clarifiers and PFRs, only the effluent 
removal change is shown (Figure 5-81 to Figure 5-82). Each CEC modeled experiences 




























































































5.4.4 Secondary Clarifier WAS Analysis 
The next variable analyzed was the secondary clarifier WAS. Because the SRT 
in the PFR is a function of the wastage flowrate (Figure 5-83), secondary clarifier WAS 
has a large effect on CEC concentrations. 
 
Figure 5-83: SRT vs. Secondary Clarifier WAS 
 
The SRT in the current NWRF layout (base model) is about 8 days. In the 
expanded model, this SRT is achieved with a WAS of approximately 2% of the influent 
flow. In the primary clarifier, as secondary clarifier WAS increases, VSS and Xa 
increase (Figure 5-84). However, the rate of increase is smaller after a WAS of about 
4.5%. Interestingly, PFR VSS and Xa increase until WAS reaches this 4.5%. After this 
point, VSS and Xa begin to decrease with increased WAS (Figure 5-85). This indicates 
a critical point for WAS, and thus SRT. As will be shown, a secondary clarifier WAS in 
this range allows for optimal removal of CECs (Figure 5-91 to Figure 5-93). 
Furthermore, plant effluent VSS and Xa levels off at a WAS of about 4.5% (Figure 























































































Figure 5-86: Effluent VSS and Xa with Varying Secondary Clarifier WAS 
 
Due to the increased VSS and Xa, secondary clarifier WAS is influential on CEC 
removal in the primary clarifiers. Almost every CEC experiences increased removal as 
WAS increases (Figure 5-87). 
 
 














































































Each CEC modeled (with the exception of iopromide) experiences increased 
primary clarifier removal percentage as secondary clarifier WAS increases. As WAS 
approaches 0%, several CECs approach 0% removal. However, some CECs experience 
an increase of about 10-15% in removal percentage as WAS approaches 8%. While 
primary clarifier removal is increased, PFR removal decreases with increased WAS 
(Figure 5-88 to Figure 5-90). After WAS reaches about 4.5%, VSS and Xa decrease, 
resulting in decreased CEC removal percentages in the PFR (Figure 5-85). 
 












































Figure 5-90: PFR CEC Removal with Varying Secondary Clarifier WAS (80-100% 
Removal) 
 
For each CEC modeled, PFR CEC removal is relatively unchanged until WAS 
reaches 3.5 to 4%. At this point, removal percentages for iohexol, DEET, and atenolol 














































































by about 2%. For this reason, 4.5% is considered a critical point for WAS, which 
corresponds to a SRT of 4.2 days. It is this range that plant CEC removal is optimum 
(Figure 5-91 to Figure 5-93). 
 






























































Figure 5-93: Plant CEC Removal with Varying Secondary Clarifier WAS (80-
100% Removal) 
 
 The critical secondary clarifier WAS range for CEC removal is between 2 and 
5% (Figure 5-91 to Figure 5-93). This critical WAS can also be seen when analyzing 
TSS, cBOD, and TKN (Figure 5-94). As shown, all three of these parameters reach a 
near-minimum point in this range. In this range, most CECs experience maximum 
removal. Secondary clarifier WAS proved to be the operational change that had the 
largest effect on CEC removal. Iohexol and DEET experience up to 5% change in 
removal percentage as WAS varies. Compared with RAS and primary clarifier volume, 
this is a significant effect. Because WAS is an operational parameter, adjusting WAS to 









































Figure 5-94: Plant Effluent TSS, cBOD, and TKN with Varying Secondary 
Clarifier WAS 
 
5.5 Advanced Model 
After the analysis of several parameters in the expanded model, the advanced 
model was developed by replacing the PFRs with membrane bioreactors (MBRs). The 
MBRs are modeled using the same volume as the PFRs, and each has three chambers. 
Unlike the PFRs in GPS-X, MBRs use internal recycle as their RAS. Rather than have a 
line from the settled matter in the secondary clarifier like with the PFR, the MBR 
recycles from the third chamber to the first. Furthermore, with the PFRs, WAS flow 
from the secondary clarifiers controls the SRT in the reactors. With the MBR, pumped 
































Figure 5-95: PFR vs. MBR Effluent, RAS, and WAS in GPS-X 
 
Because the NWRF does not currently have MBRs, the first step in modeling 
was to evaluate the sensitivity of CEC removals to changes in RAS and WAS. WAS 
from the secondary clarifier was also examined but had minimal effect on CEC 
removal. This is due to the fact that the secondary clarifier only receives filtrate water. 
Therefore, even the settled solid concentrations in the secondary clarifier are low. After 
the analysis of RAS and WAS, the optimized advanced plant could be analyzed and 
compared to the enhanced plant. 
 
5.5.1 MBR WAS Analysis 
As mentioned, WAS is one of the controlling factors in SRT. In the MBR, WAS 
is defined as the waste flowrate per MBR divided by the influent flowrate to each MBR. 
As WAS increases, SRT decreases (Figure 5-96). 
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Figure 5-96: SRT vs. MBR WAS 
 
In the primary clarifier, as WAS increases, Xa also increases. VSS reaches a 
maximum point at a WAS of 2%. After this point, it decreases until WAS reaches 
approximately 6%. As WAS approaches 10%, VSS slightly increases (Figure 5-97).  
 


















































 MBR WAS follows a similar VSS and Xa concentration pattern to secondary 
clarifier WAS with a PFR (Figure 5-84). In the MBRs, both RAS and WAS streams 
have equal concentrations. Furthermore, these streams are equal to the concentrations 
found in the third chamber of the MBR. During WAS variation, all three chambers 
follow the same VSS and Xa trends, so chambers one and two are not shown. 
 
Figure 5-98: MBR RAS and WAS Streams VSS and Xa with Varying MBR WAS 
  
While Xa decrease is gradual, VSS decreases exponentially with increased 
WAS. The dramatic decrease in VSS is likely the cause of the maximum point found in 
the primary clarifiers. At low WAS, because the VSS is largely removed by the 
membrane (Figure 5-99), higher concentrations are entering the RAS and WAS streams. 
As WAS leaves the PFR and is sent through the digesters and then to the front of the 





























































Figure 5-99: MBR Filtrate VSS and Xa with Varying MBR WAS 
 
 The membrane in the MBR largely removes VSS and Xa (Figure 5-99). The 
filtrate concentrations are within the same order of magnitude as the plant effluent 
concentrations when the PFR is used. Because filtrate concentrations are so low, the 
secondary clarifier is now essentially a polishing clarifier (Figure 5-100). 
 























































Due to the increased concentrations of VSS and Xa in primary clarifiers, CECs 
experience higher removal in the primary clarifiers as WAS increases (Figure 5-101). 
Removal patterns in the primary clarifiers are similar to those when PFRs are used and 
WAS from the secondary clarifiers increases (Figure 5-87). 
 
Figure 5-101: Primary Clarifier CEC Removal with Varying MBR WAS 
 
 




























































































 Because VSS and Xa decrease in the MBRs as WAS increases, CEC removal 
decreases (Figure 5-102). Iohexol and DEET experience close to 10% decrease in 
removal percentage, while atenolol, iopromide, and acesulfame-K about 5% change. In 
general, the rate at which MBR removal decreases is smaller than the rate which 
primary clarifier removal increases. 
Finally, the overall plant removal was analyzed. Because primary clarifier 
removal increases and MBR removal decreases, overall removal was relatively constant 
(Figure 5-103). Although gradual, CECs tend to experience change in removal 
percentage after WAS reaches about 5%, corresponding to a SRT of about 4.5 days. 
Although MBR removal percentages do not fluctuate as much as primary clarifier 
percentages, because more removal occurs in the MBRs, plant removal change is small 
(only up to 3% for DEET and iohexol). 
 





































5.5.2 MBR RAS Analysis 
In MBRs, RAS can be as high as four times (400%) larger than the influent flow 
(Davis, 2010). To ensure that the optimized RAS was chosen, it was analyzed from 100 
to 800% in each MBR. In the primary clarifiers, RAS has little effect on VSS and Xa 
concentrations (Figure 5-104). 
 
Figure 5-104: Primary Clarifier VSS and Xa with Varying RAS 
 
 Unlike in varying WAS analysis, VSS and Xa concentrations in each MBR 
chamber display different patterns as RAS increases. While VSS and Xa in the first two 
chambers increase with increasing RAS, concentrations in the third chamber decreased 
(Figure 5-105). Because RAS is pumped from the last chamber to the first, as RAS 
increases, a higher mass loading is sent from the effluent to the MBR to the influent. 
While this decreases concentrations in the third chamber, it increases concentrations in 
































Figure 5-105: MBR VSS and Xa with Varying RAS 
 
 Similar to the primary clarifiers, RAS has little effect on filtrate and plant 
effluent concentrations. Furthermore, because the membrane treats the water to low 
VSS and Xa concentrations, the secondary clarifier acts only as a polishing tank, 
without significant removal (Figure 5-106 to Figure 5-107). 
 




























































Figure 5-107: Effluent VSS and Xa with Varying RAS 
 
 Due to the small change in removal percentages in the primary clarifiers and 
MBRs, CEC data is not shown. In both, CEC removal slightly decreases as RAS 
increases. The same is true for overall plant removal. Although the change is small, as 
RAS increases, CEC removal decreases (Figure 5-108). 
 






























































 At lower RAS rates, CEC removal increases at a larger rate than it does as RAS 
approaches 800% (Figure 5-108). Regardless of the removal percentage, each CEC 
tends to decrease in removal percentage at relatively the same rate. As with the 
expanded model RAS, there is a balance between other constituents and CECs. As RAS 
increases, plant effluent VSS and Xa decrease but CEC concentrations increase. 
However, the change in removal percentage is small (<3% for most CECs) even as RAS 
approaches 800%. 
 
5.6 Expanded and Advanced Model Comparisons 
After sensitivity analyses were completed for the enhanced and advanced 
models, the two were compared to determine the improvement of MBRs in the removal 
of CECs at the NWRF. First, using these analyses, optimized WAS and RAS rates were 
determined for each model. These rates (shown below) were selected based on CEC 
removal as well as effluent VSS and Xa concentrations, attempting to find a balance 
between the parameters. The optimized parameters are as follows: 
 Expanded model: 
o Primary Clarifier WAS: 0.1% 
o Secondary Clarifier WAS: 4% 
o RAS: 70% 
 Advanced model: 
o Primary Clarifier WAS: 0.1% 
o Secondary Clarifier WAS: 4% 
o MBR WAS: 5% 
117 
o RAS: 200% 
With these parameters, the models were compared using sampling data (with 
modified flowrate). First, VSS and Xa concentrations were analyzed throughout the 
plant (Figure 5-109). The expanded model has larger concentrations of VSS and Xa in 
the preliminary and primary clarifier effluents. Secondary clarifier WAS is less 
concentrated in the advanced model because of the high removal from the membrane in 
the MBR. For this reason, because WAS is eventually returned to the front of the 
NWRF, preliminary and primary clarifier effluent VSS and Xa concentrations are lower 
in the advanced model. However, as mentioned, even when WAS approached 0%, there 
was not a significant increase in VSS or Xa concentrations (Figure 5-103). 
 
 
Figure 5-109: Preliminary and Primary Clarifier Advanced vs. Expanded Xa and 
VSS under Sampling Conditions (Modified Flowrate) 
 
 Next, VSS and Xa were analyzed in the PFR, MBR, and plant effluents. While 
































in the MBR (advanced model) increase by chamber. The averages of the three chambers 
for VSS and Xa in both models are: 
 Advanced model Xa: 2820 mg/L 
 Advanced model VSS: 4393.33 mg/L 
 Expanded model Xa: 2646.67 mg/L 
 Expanded model VSS: 3360 mg/L 
There is just a small difference in the Xa concentrations between the advanced 
and expanded models. The advanced model VSS concentration, meanwhile, is about 
30% larger than the expanded model. 
Although it is difficult to tell in the graph, expanded model plant effluent VSS 
and Xa concentrations are approximately ten times larger than concentrations in the 
advanced model (Figure 5-110). This can be attributed to the membrane, which removes 
VSS and Xa to concentrations of less than 1 mg/L. 
 
Figure 5-110: MBR or PFR Advanced vs. Expanded Xa and VSS under Sampling 




































 Because of the higher concentrations of VSS and Xa in the primary clarifiers, the 
expanded model primary clarifiers typically remove CECs slightly better than the 
advanced model primary clarifiers. PFR and MBR removal percentages are similar for 
the two models. Despite the higher levels of Xa in the MBRs, CEC removal does not 
change significantly (Figure 5-111 to Figure 5-122). 
 





























































































































































































































































































































































































































































































Figure 5-122: Expanded vs. Advanced Iohexol under Sampling Conditions 
(Modified Flowrate) 
 
 There is no significant difference in CEC removal between the expanded and 
advanced models. In the MBR membranes, GPS-X only removes soluble compounds 
when they are inert. Because the CECs are not inert in the model, they are not removed 
by the membrane. For micro- and ultrafiltration membranes, pore size is on the order of 
100 times larger than most CECs. However, some removal may take place due to 
sorption to the membrane (Lee et al., 2009). Therefore, although removal varies, actual 
CEC concentrations might be expected to be lower than levels determined in the 
advanced model. 
 While modeled soluble CECs are not shown to decrease through the membrane, 
advanced model particulate CECs are removed to lower concentrations than expanded 
model concentrations. Although effluent particulate CEC concentrations in the 
expanded model are small, advanced model filtrate and plant concentrations are 
approximately ten times smaller. Even without the secondary clarifiers, the advanced 








































Figure 5-123: Expanded vs. Advanced Particulate Meprobamate under Sampling 
Conditions (Modified Flowrate) 
 
 
Figure 5-124: Expanded vs. Advanced Particulate Triclosan under Sampling 









































































Figure 5-125: Expanded vs. Advanced Particulate Atenolol under Sampling 
Conditions (Modified Flowrate) 
 
 


































































Figure 5-127: Expanded vs. Advanced Particulate Gemfibrozil under Sampling 
Conditions (Modified Flowrate) 
 
 
Figure 5-128: Expanded vs. Advanced Particulate DEET under Sampling 











































































Figure 5-129: Expanded vs. Advanced Particulate Caffeine under Sampling 
Conditions (Modified Flowrate) 
 
 
Figure 5-130: Expanded vs. Advanced Particulate Theobromine under Sampling 





































































Figure 5-131: Expanded vs. Advanced Particulate Sucralose under Sampling 
Conditions (Modified Flowrate) 
 
 
Figure 5-132: Expanded vs. Advanced Particulate Acesulfame-K under Sampling 














































































Figure 5-133: Expanded vs. Advanced Particulate Iopromide under Sampling 
Conditions (Modified Flowrate) 
 
 
Figure 5-134: Expanded vs. Advanced Particulate Iohexol under Sampling 
Conditions (Modified Flowrate) 
 
Next, soluble CEC data was extrapolated to analyze concentrations throughout 
an entire year. Again, influent data (except an increased flowrate) from 2013 was used 
as the influent data in the extrapolated advanced model. Flowrate, as mentioned earlier, 

































































concentrations are graphed (Figure 5-135 to Figure 5-146). The expanded model 
typically outperforms the advanced model for CEC removal. However, as mentioned, 
GPS-X does not account for removal of soluble CECs in the membrane. Therefore, 
advanced model concentrations could be expected to be lower than model prediction. 
 
 
Figure 5-135: Expanded vs. Advanced Extrapolated Meprobamate 
 
 



























































































































































































































































Figure 5-141: Expanded vs. Advanced Extrapolated Caffeine 
 
 























































































































































Figure 5-143: Expanded vs. Advanced Extrapolated Sucralose 
 
 


















































































































Figure 5-146: Expanded vs. Advanced Extrapolated Iohexol 
 
 CECs that rely on biodegradation for removal (atenolol, DEET, caffeine, 
theobromine, and iohexol) typically perform equally in the advanced and expanded 
models. As mentioned earlier, meprobamate, gemfibrozil, and sucralose rate constants 






































































































less removed in the advanced model due to their dependence on adsorption. These 
trends show the importance of biodegradation in the advanced model. Because VSS 




















Chapter 6: Conclusion 
With the rise in popularity of direct and indirect water reuse, CECs are of 
growing concern to both ecosystems and human consumption. Because direct and 
indirect reuse can include wastewater effluent application to natural streams, lakes, 
irrigated land, and even water treatment plants, it is desirable to understand CEC 
concentrations and removal patterns throughout WWTPs. Due to the wide range of 
WWTP characteristics, CEC removal varies greatly and can be difficult to predict 
without knowledge and information of the specific plant. This research uses a stochastic 
model to analyze CEC removal through the various treatment processes at the NWRF. 
Using the commercial software GPS-X, CECs are analyzed with varying RAS, WAS, 
SRTs, and HRTs. GPS-X incorporates the use of the model developer tool, which uses 
matrix format to model the relationships between model parameters and CECs that are 
added to the model. This research evaluates operational effects at the NWRF on CEC 
removal. Additionally, it analyzes the use of MBRs instead of PFRs and evaluates 
advanced treatment options for CEC removal. 
CECs are primarily removed from wastewater by biodegradation and adsorption 
to biosolids. At low CEC concentrations, both biodegradation and adsorption are first-
order reactions with respect to Xa and VSS concentrations, respectively. While most 
reclamation facilities use CAS, other treatment techniques include MBRs, RO and other 
membrane processes, and UV disinfection. In the NWRF, CECs are most significantly 
removed in the primary clarifiers and the PFR. Because of the high concentrations of Xa 
and VSS, these treatment processes are able to remove CECs. Of 98 CECs analyzed, 
only 38 are larger than the MRL in one or more of the treatment processes. 
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Furthermore, influent and effluent indicator CEC concentrations are well below MTT 
levels. There are some general trends from biodegradation and adsorption that can be 
seen from CEC removal: 
 CECs that are predominantly removed in the PFR (caffeine, 
theobromine, iopromide, and acesulfame-K) are heavily biodegraded in 
the PFR and experience removal from both biodegradation and 
adsorption in the primary clarifiers. These CECs have the highest 
removal percentages (>94%) of all indicator and validator CECs in the 
study. 
 CECs that are mostly removed in the primary clarifiers (sucralose, 
meprobamate, and gemfibrozil) rely on adsorption in both the primary 
clarifiers and the PFR. These CECs have the lowest removal percentages 
(<30%) of modeled CECs in the NWRF. 
 CECs that show steady and equal removal through both the primary 
clarifiers and the PFR (atenolol, iohexol, DEET) tend to favor 
biodegradation in both treatment processes. These CECs have removal 
percentages between 39 and 91% from the NWRF. 
RAS and WAS are operational effects that can help reduce CEC concentrations 
in WWTPs. However, as with most engineered processes, there is a balance between 
CEC concentrations and plant performance for others contaminants. As mentioned, 
biodegradation and adsorption are first-order rates with respect to Xa and VSS. 
Therefore, at higher levels of Xa and VSS, CEC removal rates increase. RAS has 
varying effects on removal. While some CECs experience increased removal with 
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increasing RAS, other CECs decrease in removal. CECs that rely more heavily on 
biodegradation for removal tend to increase in removal percentage as RAS increases. 
However, RAS has a small effect on overall CEC removal, with each CEC experiencing 
less than 4% change in removal percentage. 
Because it controls SRT, secondary clarifier WAS has a larger effect on CEC 
removal than RAS. Interestingly, there seems to be a clear critical point with WAS 
flowrate. As WAS approaches 4 to 5%, removal percentage of each CEC is optimized. 
This confirms current literature (Clara et al., 2005a; Monteith et al., 2008; Jelić et al., 
2012) that suggests that critical SRT (and consequentially WAS) can be determined to 
optimize CEC removal. In these studies, as SRT increases, CEC removal increases but 
generally reaches a maximum percentage. In the model, at this critical WAS, plant 
effluent VSS and Xa reach a low point and are maintained with increasing WAS. Unlike 
RAS, there is a clear optimum WAS rate in which CEC removal is maximized and plant 
effluent VSS and Xa are minimized. For these reasons, adjustment of the secondary 
clarifier WAS is a more viable operational change to the NWRF for CEC removal.  
In GPS-X, MBRs do not significantly increase soluble removal percentages of 
any of the CECs modeled. However, because of the membrane filter, particulate CECs 
are removed approximately ten times greater in the MBRs than they are in the PFRs and 
secondary clarifiers of the expanded model. Although particulate removal depends on 
the membrane used, Clara et al. (2005b) and Radjenović et al. (2006) confirm that 
particulate matter is detained by an ultrafiltration membrane, resulting in negligible 
concentrations of suspended solids in the effluent.  In this research, modeled MBR 
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filtrate VSS and Xa concentrations are also about ten times smaller than expanded 
model plant effluent concentrations, eliminating the need for the secondary clarifiers.  
Changes in WAS or RAS in the MBRs did not show a large effect on modeled 
CEC removal. In contrast, literature finds that increased SRT (decreased WAS) 
increases CEC removal. Longer SRTs result in diversified biomass, allowing for higher 
removal (Kimura et al., 2007; Radjenović et al., 2009). This research did not account 
for biomass diversification, which could be a reason that increased SRTs only slightly 
increase CEC removal. Although GPS-X does not show the removal of soluble CECs 
with the membrane, several studies (Kimura et al., 2005; Lee et al., 2009; Sipma et al., 
2010; Snyder et al., 2007) show that CEC removal is a function of the type of 
membrane used, pressure, flux, and molecular weight of the CEC. Furthermore, UV 
disinfection removal depends on intensity-time values and can be as large as 90% 
(Canonica et al., 2008; Kim et al., 2009). So, although modeled MBR removal is similar 
to PFR removal, AT techniques, if properly applied, can help to remove CECs in 
WWTPs. This is in agreement with literature information, confirming that AT processes 
can increase CEC removal when compared to CAS systems. 
As mentioned, both influent and effluent CEC concentrations in the NWRF are 
below MTT levels. The models in this research suggest that the plant expansion (even 
with increased flowrate) might slightly decrease removal percentages of CECs, but not 
at a level that should cause concern. If concentrations do rise to levels approaching the 
MTT, WAS could be an effective parameter to increase removal percentage of the 
overall plant. Several studies (Clara et al., 2005a; Monteith et al., 2008; Jelić et al., 
2012) show that determining critical SRT (which is controlled by WAS) can enhance 
143 
CEC removal in CAS systems. MBRs, though, have the potential to increase removal 
percentage greater than operational changes can. As mentioned, CECs that are sorbed to 
biomass (particulate CECs) can be expected to be smaller in effluent concentrations if 
MBRs are utilized. Furthermore, research suggests that soluble CECs can experience 
higher removal depending on the type of membrane used. 
The following is a summary of limitations that are also noted throughout the 
paper: 
 CECs were only collected during one sampling day. In order to better 
evaluate removal, more data from various months of the year is 
desirable. 
 CEC analysis did not indicate whether the CEC was ionized or neutral. 
This could have some effect on removal in the plant. 
 GPS-X, while extensive and robust for suspended and attached growth 
processes, does not allow for the modeling of some AT processes, like 
UV disinfection and membrane filtration. Furthermore, CEC removal 
mechanisms are not able to be modeled in the digesters. 
 MBR membranes do not remove soluble matter in GPS-X. The model 
does not allow for the input of size, pressure, or other characteristics 
needed for membrane filtration. 
Based on the mentioned limitations and on the research as a whole, the 
following recommendations are made: 
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 If possible, more sampling should be completed. Seasonal and even daily 
variations of CECs are possible and more data would allow for a more 
finely calibrated mode. 
 Because of the lack of model capability for AT processes and the wide 
range of removal percentages, pilot or bench-scale testing is likely the 
most ideal option for understanding removal through AT processes. 
 In CAS processes, sampling and analysis of CECs only in the primary 
clarifiers and PFRs can save time and money. These unit processes 
account for the majority of removal in CAS WWTPs. 
As direct and indirect water reuse becomes increasingly popular, information 
regarding CEC removal in WWTPs is needed. This research helps to understand CEC 
removal in the NWRF. Using a stochastic model, it is able to evaluate and quantify the 
key removal mechanisms in CAS treatment processes, operational improvements to 
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1/1/12 8.445 18.2 7.4 164 265 27.8 1.2 17.8 7.2 7 3 1.1 7.2 
1/2/12 9.033 15.6 7.5 208 253 
 
1.5 15.0 7.3 5 2 
 
6.5 
1/3/12 8.968 15.5 7.6 136 232 
 
1.3 15.0 7.2 4 2 0.1 6.4 
1/4/12 8.842 15.7 7.7 112 214 
 
1.4 14.9 7.3 20 4 
 
6.3 
1/5/12 8.867 15.8 7.6 156 222 26.7 1.5 15.5 7.3 4 2 0.1 6.5 
1/6/12 8.671 15.8 7.5 
   
1.1 15.7 7.3 
   
6.3 
1/7/12 8.853 15.2 7.6 
   
1.7 15.3 7.4 
   
7.0 
1/8/12 9.116 15.4 7.5 216 234 29.8 1.3 15.4 7.3 4 3 0.4 6.3 
1/9/12 8.749 15.5 7.7 140 227 
 
1.5 14.8 7.3 4 2 
 
6.3 
1/10/12 8.586 15.3 7.6 144 227 
 
1.3 15.0 7.2 4 2 0.2 6.3 
1/11/12 8.739 15.8 7.8 160 239 
 
1.3 15.3 7.3 5 2 
 
6.1 
1/12/12 8.603 15.0 7.7 136 245 26.6 1.4 13.1 7.4 4 2 0.6 6.9 
1/13/12 8.953 15.3 7.7 
   
1.4 14.3 7.3 
   
6.5 
1/14/12 8.941 15.1 7.5 
   
1.4 14.9 7.1 
   
6.9 
1/15/12 8.931 15.1 7.5 180 202 27.6 1.4 15.1 7.3 29 5 0.2 6.5 
1/16/12 9.485 15.3 7.7 160 255 
 
1.6 15.5 7.3 4 2 
 
6.6 
1/17/12 9.085 15.4 7.7 152 237 
 
1.3 14.2 7.3 4 2 0.1 6.4 
1/18/12 9.346 15.4 7.8 196 242 
 
1.4 14.6 7.3 3 2 
 
6.7 
1/19/12 9.147 15.8 7.8 160 323 23.6 1.4 15.0 7.3 3 2 0.1 6.5 
1/20/12 9.039 15.7 7.7 
   
1.5 15.2 7.0 
   
6.5 
1/21/12 8.960 14.6 7.7 
   
1.7 14.0 7.3 
   
6.8 
1/22/12 9.173 15.0 7.7 164 259 25.7 1.6 14.7 7.1 8 2 0.1 6.6 
1/23/12 9.299 15.1 7.7 160 251 
 
2.5 15.0 7.3 6 4 
 
6.6 
1/24/12 9.256 15.3 7.7 204 248 
 
1.3 15.0 7.1 16 5 0.7 6.6 
1/25/12 14.085 13.6 7.8 132 179 
 
2.4 14.1 7.3 36 10 
 
6.3 
1/26/12 10.003 15.1 7.8 212 205 38.8 1.4 14.3 7.3 8 4 0.1 6.8 
1/27/12 10.357 15.1 7.7 
   
1.6 14.8 7.3 
   
6.4 
1/28/12 10.301 14.0 7.5 
   
1.8 14.5 7.1 
   
6.5 
1/29/12 9.557 15.4 7.6 164 276 31.0 1.5 15.1 7.3 12 4 0.1 6.5 
1/30/12 9.431 15.2 7.5 210 268 
 
1.2 15.3 7.3 14 3 
 
6.4 
1/31/12 9.584 16.0 7.4 264 299 
 
1.0 16.0 7.3 16 4 0.1 5.9 
2/1/12 9.040 15.8 7.7 164 261 
 
1.0 15.7 7.2 18 4 
 
6.1 
2/2/12 9.045 15.8 7.7 144 238 29.4 1.2 15.5 7.3 6 2 0.1 6.7 
2/3/12 9.665 15.7 7.5 
   
0.9 15.9 7.3 
   
6.7 
152 
2/4/12 9.177 14.7 7.6 
   
1.2 14.6 7.5 
   
6.9 
2/5/12 9.392 15.1 7.6 172 240 28.6 1.4 14.8 7.4 2 2 0.1 6.9 
2/6/12 9.006 15.4 7.6 160 251 
 
1.4 14.9 7.3 2 2 
 
6.9 
2/7/12 9.050 15.7 7.7 164 235 
 
1.5 15.2 7.2 2 2 0.1 6.6 
2/8/12 9.005 15.1 7.7 156 218 
 
1.6 14.3 7.2 2 2 
 
6.8 
2/9/12 8.885 15.1 7.7 160 244 28.9 1.6 14.2 7.2 2 2 0.1 6.6 
2/10/12 9.276 14.8 7.7 
   
1.6 14.4 7.2 
   
7.0 
2/11/12 9.326 13.8 7.4 
   
1.5 13.0 7.0 
   
6.0 
2/12/12 9.461 14.2 7.6 180 282 21.1 1.3 13.1 7.2 4 2 0.1 6.5 
2/13/12 9.993 14.0 7.7 196 242 
 
1.4 13.0 7.3 3 2 
 
6.7 
2/14/12 9.425 14.6 7.7 144 212 
 
1.6 13.7 7.1 3 2 0.1 6.6 
2/15/12 9.647 15.0 7.6 156 213 
 
1.7 15.2 7.2 3 2 
 
6.4 
2/16/12 9.361 15.1 7.8 164 229 23.0 1.8 14.9 7.2 3 2 0.1 7.0 
2/17/12 9.612 15.0 7.7 
   
1.9 15.0 7.3 
   
6.8 
2/18/12 9.760 14.3 7.6 
   
1.6 14.7 7.4 
   
6.9 
2/19/12 9.722 15.1 7.5 252 309 22.4 1.7 15.5 7.2 4 2 0.1 6.9 
2/20/12 9.722 14.8 7.6 176 205 
 
1.6 14.4 7.2 7 2 
 
6.6 
2/21/12 9.621 14.9 7.6 120 204 
 
1.7 15.0 7.2 6 2 0.3 6.9 
2/22/12 9.502 15.3 7.6 180 233 
 
1.7 15.4 7.2 6 2 
 
6.5 
2/23/12 9.532 15.4 7.5 168 228 26.6 1.5 15.8 7.0 14 4 0.1 6.5 
2/24/12 9.912 14.7 7.6 
   
1.5 15.0 7.0 
   
6.6 
2/25/12 9.811 14.9 7.5 
   
2.0 15.3 7.3 
   
6.5 
2/26/12 9.724 15.4 7.5 160 227 21.9 1.9 15.4 7.1 12 4 0.2 7.9 
2/27/12 9.418 15.4 7.6 152 236 
 
1.3 15.1 7.1 26 4 
 
6.2 
2/28/12 9.612 15.4 7.6 216 287 
 
1.9 15.6 7.1 81 5 0.5 6.7 
2/29/12 9.253 15.8 7.5 156 241 
 
1.3 15.9 7.2 30 4 
 
5.3 
3/1/12 9.413 15.9 7.5 151 281 38.6 1.9 16.1 7.1 21 8 0.8 6.3 
3/2/12 9.350 15.4 7.6 
   
1.1 15.5 7.2 
   
6.4 
3/3/12 9.288 14.9 7.6 
   
1.5 15.0 7.3 
   
6.5 
3/4/12 9.401 15.9 7.5 184 255 21.7 1.3 16.1 7.1 31 4 0.1 6.3 
3/5/12 9.436 15.7 7.4 132 249 
 
1.2 16.0 7.1 11 3 
 
6.2 
3/6/12 9.319 15.5 7.6 248 279 
 
1.2 15.6 7.1 28 4 0.1 6.3 
3/7/12 9.214 16.2 7.6 228 252 
 
1.2 16.3 7.1 22 5 
 
6.3 
3/8/12 9.204 15.0 7.6 180 223 37.1 1.1 14.3 7.2 17 5 0.1 6.3 
3/9/12 9.097 15.7 7.6 
   
1.2 15.1 7.2 
   
6.8 
3/10/12 9.416 15.3 7.5 
   
1.6 15.5 7.3 
   
6.6 
3/11/12 13.343 14.4 7.4 196 220 21.9 1.3 15.0 7.1 148 10 0.3 5.6 
3/12/12 11.011 15.9 7.7 200 197 
 
1.2 15.7 7.2 18 5 
 
6.2 
3/13/12 10.276 16.0 7.7 260 230 
 
1.2 16.8 7.3 15 4 0.1 6.2 
3/14/12 10.121 16.1 7.7 304 256 
 




3/15/12 10.105 16.3 7.6 164 234 26.4 1.3 17.5 7.2 15 4 0.5 6.2 
3/16/12 10.035 16.5 7.5 
   
1.2 17.7 7.3 
   
6.4 
3/17/12 9.650 15.0 7.5 
   
1.4 17.0 7.3 
   
6.3 
3/18/12 9.127 16.0 7.5 164 242 24.8 1.4 17.0 7.2 48 4 1.0 6.4 
3/19/12 17.167 14.5 7.1 252 134 
 
0.5 15.3 7.2 334 28 
 
5.2 
3/20/12 19.212 14.7 7.6 200 165 
 
3.3 14.6 7.2 13 7 3.6 5.8 
3/21/12 14.985 15.0 7.6 336 247 
 
1.9 15.2 7.3 16 5 
 
6.4 
3/22/12 14.090 14.5 7.6 176 144 17.2 1.1 14.9 7.2 10 7 3.3 6.2 
3/23/12 12.189 15.4 7.7 
   
1.3 15.7 7.3 
   
6.6 
3/24/12 10.750 15.1 7.6 
   
1.5 15.2 7.3 
   
6.7 
3/25/12 11.491 16.1 7.6 132 202 21.6 1.3 17.8 7.4 4 2 0.1 6.7 
3/26/12 11.583 16.7 7.6 148 217 
 
1.1 17.4 7.2 5 2 
 
6.6 
3/27/12 11.283 16.9 7.6 130 215 
 
1.5 17.8 7.1 4 2 1.2 6.4 
3/28/12 11.441 16.4 7.4 388 245 
 
0.8 17.5 7.2 6 2 
 
6.1 
3/29/12 11.883 17.2 7.6 136 221 28.4 1.5 18.0 7.3 8 3 0.4 6.3 
3/30/12 14.604 17.2 7.6 
   
1.4 18.1 7.2 
   
6.0 
3/31/12 9.667 17.1 7.5 
   
1.4 17.1 7.2 
   
6.2 
4/1/12 9.799 17.5 7.5 164 205 25.6 1.6 19.0 7.0 34 4 2.0 6.2 
4/2/12 9.616 18.8 7.5 148 197 
 
1.2 20.0 7.2 16 4 
 
5.8 
4/3/12 11.339 18.1 7.5 172 212 
 
1.2 18.6 7.2 14 5 1.7 6.0 
4/4/12 10.048 18.5 7.7 192 173 
 
1.2 19.0 7.3 20 4 
 
6.1 
4/5/12 9.521 18.4 7.5 156 186 26.7 1.2 18.8 7.2 16 4 0.3 6.0 
4/6/12 9.473 18.3 7.5 
   
0.7 18.8 7.2 
   
6.1 
4/7/12 9.449 17.2 7.5 
   
1.4 18.5 7.2 
   
6.2 
4/8/12 9.229 17.5 7.4 168 216 24.6 1.2 17.8 7.2 31 5 0.2 5.8 
4/9/12 9.399 17.8 7.5 156 198 
 
1.2 18.3 7.3 30 4 
 
5.8 
4/10/12 9.265 18.0 7.5 144 245 
 
1.3 18.6 7.2 21 5 1.3 5.7 
4/11/12 9.270 18.1 7.5 160 232 
 
1.2 18.7 7.2 26 7 
 
5.9 
4/12/12 9.189 18.0 7.5 140 226 28.9 1.1 19.1 7.3 132 8 0.2 5.6 
4/13/12 10.168 20.0 7.8 
   
1.0 20.8 7.2 
   
5.7 
4/14/12 9.935 19.7 7.4 
   
1.2 20.7 7.1 
   
5.8 
4/15/12 11.353 19.0 7.4 184 227 23.5 1.1 20.3 7.0 37 7 0.2 6.3 
4/16/12 9.781 20.1 7.6 140 187 
 
1.0 20.4 7.2 64 6 
 
6.0 
4/17/12 9.375 20.1 7.6 148 185 
 
1.3 20.7 7.2 33 5 0.4 5.9 
4/18/12 9.541 20.3 7.5 144 195 
 
1.2 21.5 7.3 61 6 
 
5.8 
4/19/12 9.447 20.2 7.6 160 186 23.9 1.4 20.8 7.3 22 3 1.0 5.9 
4/20/12 10.953 19.9 7.5 
   
1.3 20.2 7.2 
   
5.6 
4/21/12 9.628 19.9 7.5 
   
1.3 20.6 7.2 
   
5.3 
4/22/12 9.532 20.4 7.5 136 202 28.0 1.2 20.6 7.3 40 6 0.2 5.7 
4/23/12 9.227 20.5 7.4 140 207 
 




4/24/12 9.297 20.6 7.5 152 216 
 
1.3 21.2 7.2 20 5 0.9 5.9 
4/25/12 9.454 20.9 7.5 148 216 
 
1.2 21.9 7.2 41 5 
 
5.5 
4/26/12 9.370 21.1 7.4 148 203 24.5 1.3 22.0 7.1 74 6 0.5 5.5 
4/27/12 9.436 21.0 7.4 
   
1.3 22.5 7.0 
   
5.6 
4/28/12 9.432 20.6 7.4 
   
1.5 22.2 7.3 
   
5.8 
4/29/12 9.601 21.2 7.3 144 224 25.2 1.3 22.6 7.1 43 5 1.1 6.0 
4/30/12 9.586 21.3 7.4 172 245 
 
0.9 22.1 7.1 21 4 
 
5.8 
5/1/12 9.977 21.3 7.4 168 213 
 
1.1 22.9 7.1 112 11 0.1 5.6 
5/2/12 9.713 21.2 7.5 172 210 
 
1.0 22.4 7.1 56 8 
 
5.6 
5/3/12 9.500 21.8 7.4 144 224 27.4 1.3 23.2 7.1 79 10 1.5 5.5 
5/4/12 9.414 21.8 7.3 
   
0.9 22.6 7.1 
   
5.5 
5/5/12 9.554 21.7 7.3 
   
1.2 23.7 7.2 
   
5.6 
5/6/12 9.573 22.1 7.3 176 236 26.8 1.0 24.0 7.1 118 10 1.5 5.3 
5/7/12 9.173 21.6 7.3 140 223 
 
1.2 22.3 7.0 79 10 
 
5.6 
5/8/12 8.945 21.5 7.3 140 221 
 
1.1 22.3 7.1 34 7 1.5 5.5 
5/9/12 8.892 21.8 7.3 148 210 
 
1.1 22.6 7.2 81 10 
 
5.3 
5/10/12 8.758 22.3 7.1 580 217 21.3 1.3 22.7 6.6 155 9 0.5 5.0 
5/11/12 9.774 21.1 7.4 
   
1.1 21.7 7.2 
   
5.6 
5/12/12 9.782 21.5 7.3 
   
1.2 22.1 7.2 
   
5.7 
5/13/12 9.014 22.0 7.1 148 216 23.3 1.0 22.9 7.0 40 5 0.9 5.5 
5/14/12 8.727 21.6 7.2 132 221 
 
1.1 22.6 7.1 27 6 
 
5.5 
5/15/12 8.466 21.9 7.2 148 219 
 
1.1 23.0 7.1 18 6 0.6 5.4 
5/16/12 9.033 22.1 7.3 188 214 
 
1.1 23.2 7.1 20 5 
 
5.5 
5/17/12 9.326 22.2 7.3 128 207 25.2 1.0 23.1 7.0 25 6 0.7 5.4 
5/18/12 9.132 22.0 7.2 
   
1.1 23.2 7.0 
   
5.7 
5/19/12 8.989 22.3 7.0 
   
1.1 23.7 7.0 
   
5.8 
5/20/12 9.539 21.5 7.1 180 225 31.4 1.1 22.0 7.1 10 7 0.5 5.8 
5/21/12 9.238 22.3 7.1 156 235 
 
0.8 22.9 7.0 7 5 
 
6.0 
5/22/12 9.093 22.6 7.2 152 219 
 
1.1 23.3 7.1 7 4 1.4 5.8 
5/23/12 9.198 22.3 7.2 116 203 
 
0.8 23.7 7.0 32 9 
 
5.7 
5/24/12 9.326 22.2 7.3 152 222 33.5 1.2 23.8 6.9 44 6 4.1 5.3 
5/25/12 9.488 22.7 7.2 
   
1.2 24.5 6.9 
   
5.5 
5/26/12 8.891 22.5 7.1 
   
1.1 23.7 6.9 
   
5.8 
5/27/12 8.365 22.9 7.1 196 231 29.7 1.0 25.1 6.9 20 5 2.8 5.7 
5/28/12 8.598 22.1 7.2 152 230 
 
1.3 24.5 7.0 12 4 
 
5.9 
5/29/12 8.993 22.9 7.3 272 253 
 
0.9 24.4 7.1 10 5 4.2 5.4 
5/30/12 11.202 22.6 7.4 124 194 
 
1.2 23.9 7.0 12 6 
 
5.4 
5/31/12 8.785 22.4 7.3 140 223 29.1 1.0 23.6 7.0 13 7 2.6 5.7 
6/1/12 8.485 22.6 7.3 
   
1.4 23.4 7.0 
   
5.5 
6/2/12 9.087 22.7 7.3 
   
1.1 23.6 7.1 
   
5.8 
155 
6/3/12 9.186 23.4 7.1 140 196 25.4 1.0 25.0 7.0 6 4 7.2 5.7 
6/4/12 8.739 23.2 7.3 124 189 
 
1.4 24.6 7.0 6 4 
 
5.7 
6/5/12 8.448 23.8 7.1 108 202 
 
1.2 25.1 6.8 4 5 2.7 5.6 
6/6/12 9.259 22.9 7.2 176 236 
 
1.2 24.3 7.0 6 6 
 
5.7 
6/7/12 10.750 22.2 7.1 200 251 26.0 1.4 23.8 7.1 7 5 2.5 5.8 
6/8/12 8.985 23.3 7.2 
   
1.0 24.5 7.1 
   
5.7 
6/9/12 8.980 23.3 7.2 
   
1.1 25.3 7.1 
   
5.9 
6/10/12 8.922 23.5 7.1 140 201 25.2 1.2 26.2 7.0 4 2 2.0 5.7 
6/11/12 9.621 23.4 7.0 184 157 
 
1.1 25.1 7.0 3 3 
 
5.7 
6/12/12 9.683 23.3 7.2 128 217 
 
1.8 24.8 6.9 6 4 4.6 5.8 
6/13/12 9.444 23.2 7.1 159 217 
 
1.9 24.6 7.0 5 4 
 
5.8 
6/14/12 9.139 23.5 7.1 176 231 23.4 1.6 25.2 6.9 6 6 1.9 5.8 
6/15/12 9.088 23.6 7.2 
   
1.5 25.5 7.0 
   
5.7 
6/16/12 9.010 23.8 7.1 
   
1.9 25.9 7.0 
   
5.9 
6/17/12 8.890 24.2 7.1 132 236 23.9 1.8 26.5 7.0 4 3 2.9 5.9 
6/18/12 8.912 23.5 7.1 176 259 
 
1.5 25.5 6.9 4 3 
 
5.7 
6/19/12 9.061 23.6 7.1 176 238 
 
1.9 25.4 6.9 5 4 3.9 5.7 
6/20/12 9.124 24.0 7.1 164 243 
 
1.4 25.4 6.9 8 5 
 
5.6 
6/21/12 8.947 23.7 7.2 148 232 33.2 1.2 25.1 6.9 11 5 1.6 5.5 
6/22/12 8.852 23.6 7.2 
   
1.0 25.4 7.0 
   
5.4 
6/23/12 8.869 24.3 7.2 
   
1.1 26.7 7.1 
   
5.4 
6/24/12 8.627 25.0 7.1 132 252 34.1 1.0 25.6 7.1 7 8 16.3 5.6 
6/25/12 8.496 24.7 7.1 124 227 
 
1.2 26.5 6.8 7 5 
 
5.1 
6/26/12 8.822 24.6 7.2 132 272 
 
1.0 26.6 6.9 5 3 2.7 5.2 
6/27/12 9.106 25.0 7.1 144 225 
 
1.0 26.8 7.0 5 4 
 
5.7 
6/28/12 8.941 25.1 7.1 152 253 29.0 1.0 26.6 7.0 5 4 2.0 5.6 
6/29/12 9.076 25.5 7.0 
   
1.0 26.7 7.0 
   
5.6 
6/30/12 8.697 24.8 7.1 
   
1.1 26.6 7.0 
   
5.3 
7/1/12 8.680 25.1 7.1 132 208 21.5 1.0 27.3 7.1 4 3 0.9 5.4 
7/2/12 8.652 24.7 7.1 124 195 
 
1.2 27.0 7.0 6 4 
 
5.7 
7/3/12 8.887 25.2 7.2 128 186 
 
0.9 26.4 7.1 6 4 1.4 5.6 
7/4/12 8.567 25.2 7.1 108 196 
 
1.2 27.2 7.0 5 4 
 
5.4 
7/5/12 8.604 24.8 7.2 108 217 34.2 1.1 26.8 7.1 4 4 0.4 5.5 
7/6/12 8.747 25.2 7.2 
   
0.9 26.9 7.2 
   
5.7 
7/7/12 8.667 25.3 7.3 
   
1.2 27.0 7.2 
   
5.5 
7/8/12 8.589 25.0 7.1 140 252 26.3 1.0 26.5 7.1 5 4 0.7 5.3 
7/9/12 8.625 25.0 7.2 160 229 
 
0.9 26.9 7.3 5 4 
 
5.6 
7/10/12 8.973 25.3 7.2 180 280 
 
1.2 26.8 7.2 5 4 0.3 5.4 
7/11/12 8.834 25.6 7.3 148 212 
 
0.8 26.7 7.2 6 5 
 
5.5 
7/12/12 8.500 25.8 7.3 132 230 37.1 1.0 27.0 7.2 5 4 0.5 5.3 
156 
7/13/12 8.616 25.4 7.3 
   
1.0 27.1 7.2 
   
5.3 
7/14/12 8.840 25.7 7.2 
   
1.2 27.6 7.1 
   
5.5 
7/15/12 8.412 25.9 7.1 152 242 27.5 1.1 27.6 7.1 4 4 0.8 5.4 
7/16/12 8.685 25.8 6.6 168 225 
 
0.7 27.1 7.2 5 4 
 
5.2 
7/17/12 8.772 25.7 7.3 136 305 
 
1.2 27.2 7.1 5 6 2.0 5.6 
7/18/12 8.763 25.9 7.2 140 214 
 
1.1 27.2 7.1 6 6 
 
5.5 
7/19/12 8.479 25.8 7.2 172 216 25.1 1.0 27.5 7.1 7 7 1.1 5.7 
7/20/12 8.453 26.3 7.3 
   
0.9 27.6 7.1 
   
5.7 
7/21/12 8.491 26.3 7.2 
   
1.1 28.1 7.1 
   
5.1 
7/22/12 8.533 26.5 7.1 132 243 29.9 1.0 28.6 7.0 6 4 0.6 5.2 
7/23/12 8.756 26.3 7.2 148 212 
 
0.9 27.6 7.1 4 4 
 
6.0 
7/24/12 8.911 26.0 7.3 120 203 
 
1.1 27.5 7.1 5 4 1.0 5.4 
7/25/12 8.708 26.1 7.2 128 218 
 
0.9 27.7 7.1 7 5 
 
5.5 
7/26/12 8.636 26.0 7.2 136 190 37.0 0.8 27.5 7.1 8 3 0.3 5.3 
7/27/12 8.574 26.2 7.1 
   
1.1 27.7 7.1 
   
5.5 
7/28/12 8.538 26.7 7.2 
   
1.0 28.5 7.1 
   
5.5 
7/29/12 8.259 27.1 7.1 146 203 28.8 1.0 28.8 7.1 3 3 0.3 5.3 
7/30/12 8.404 26.6 7.3 151 208 
 
1.1 27.7 7.1 6 4 
 
5.5 
7/31/12 8.565 26.4 7.2 140 205 
 
1.1 28.3 7.2 8 4 0.9 5.4 
8/1/12 8.296 26.7 7.2 132 191 
 
1.0 28.7 7.1 6 4 
 
5.3 
8/2/12 8.430 26.5 7.2 204 219 30.4 1.1 28.3 7.0 5 3 0.2 5.4 
8/3/12 8.217 26.5 7.2 
   
1.0 28.1 7.1 
   
5.1 
8/4/12 8.664 26.8 7.2 
   
1.1 28.6 7.2 
   
5.2 
8/5/12 8.472 27.2 7.1 124 210 38.9 0.9 28.5 7.1 6 4 0.3 5.0 
8/6/12 8.293 26.8 7.2 144 225 
 
0.9 28.1 7.2 5 5 
 
5.2 
8/7/12 8.646 26.6 7.2 160 207 
 
1.1 28.2 7.1 5 5 0.2 5.1 
8/8/12 8.371 26.6 7.3 172 219 
 
0.9 28.4 7.2 4 2 
 
5.3 
8/9/12 8.638 27.2 7.1 132 191 25.9 1.0 28.5 7.0 2 2 0.1 5.5 
8/10/12 8.227 26.9 7.2 
   
1.0 28.3 7.1 
   
5.5 
8/11/12 8.467 27.0 7.2 
   
0.9 27.7 7.2 
   
5.5 
8/12/12 8.489 27.2 7.1 180 226 22.7 0.8 28.5 7.0 7 7 2.0 5.0 
8/13/12 8.304 26.7 7.2 148 255 
 
1.1 27.9 7.1 4 3 
 
5.5 
8/14/12 8.599 26.5 7.2 172 198 
 
1.0 27.7 7.1 3 2 0.4 5.5 
8/15/12 8.806 26.6 7.2 136 218 
 
1.1 27.7 7.1 3 2 
 
5.4 
8/16/12 9.322 26.3 7.3 168 162 28.7 1.0 27.3 7.0 2 2 0.1 5.4 
8/17/12 8.657 26.5 7.3 
   
0.9 27.5 7.0 
   
5.6 
8/18/12 10.740 26.7 7.3 
   
0.9 27.5 7.1 
   
5.6 
8/19/12 9.457 27.0 7.2 172 236 22.3 0.8 27.5 7.0 2 2 0.2 5.0 
8/20/12 8.867 26.8 7.3 148 227 
 
1.2 27.4 7.0 3 3 
 
5.6 
8/21/12 9.114 26.6 7.1 136 211 
 
0.9 27.8 6.9 4 3 0.1 5.5 
157 
8/22/12 8.979 26.7 7.2 148 230 
 
1.1 27.8 7.0 4 4 
 
5.6 
8/23/12 8.481 26.6 7.1 160 227 25.7 1.1 27.4 6.9 6 3 1.5 5.6 
8/24/12 8.763 26.8 7.1 
   
1.0 27.5 7.0 
   
5.4 
8/25/12 9.263 26.7 7.2 
   
1.0 28.1 7.0 
   
5.5 
8/26/12 12.063 26.2 7.2 152 176 24.0 1.3 27.2 7.0 8 4 2.2 5.4 
8/27/12 9.271 26.7 7.2 160 202 
 
1.2 27.7 7.0 8 4 
 
5.4 
8/28/12 9.241 26.0 7.2 140 146 
 
1.5 27.8 6.9 6 2 0.7 5.3 
8/29/12 8.604 26.4 7.2 133 291 
 
1.2 27.6 7.0 6 4 
 
5.6 
8/30/12 8.806 26.9 7.3 118 203 31.1 0.9 27.7 7.0 4 3 0.2 5.5 
8/31/12 8.673 26.5 7.2 
   
1.0 28.0 7.2 
   
5.6 
9/1/12 8.553 26.8 7.0 
   
1.3 28.7 6.9 
   
5.8 
9/2/12 8.328 26.2 7.1 125 186 28.6 1.6 29.0 7.0 3 2 0.3 5.9 
9/3/12 9.176 27.1 6.9 136 218 
 
1.3 28.7 6.9 3 2 
 
5.4 
9/4/12 8.763 26.6 7.2 160 213 
 
1.2 28.3 7.0 4 2 0.2 5.5 
9/5/12 8.566 27.1 7.2 148 215 
 
1.1 28.4 7.0 3 2 
 
5.9 
9/6/12 8.798 27.1 7.2 140 189 30.4 1.2 28.3 6.9 3 2 0.3 5.7 
9/7/12 8.321 27.0 7.2 
   
0.6 28.4 6.6 
   
5.6 
9/8/12 9.530 26.0 6.9 
   
1.2 27.0 6.9 
   
5.7 
9/9/12 8.795 25.5 7.1 176 241 24.8 1.2 27.4 6.8 4 2 0.2 6.3 
9/10/12 8.460 26.7 7.2 148 219 
 
0.5 27.3 7.0 3 2 
 
5.7 
9/11/12 8.715 26.6 7.2 156 190 
 
0.8 27.2 7.0 4 2 0.0 5.8 
9/12/12 8.623 26.8 7.3 160 217 
 
0.5 27.2 7.0 2 2 
 
6.0 
9/13/12 8.785 26.1 7.3 152 254 34.6 1.2 26.3 7.1 2 2 0.2 6.1 
9/14/12 8.481 25.8 7.2 
   
1.1 25.2 7.0 
   
5.6 
9/15/12 8.744 25.5 7.0 
   
1.1 25.6 6.9 
   
5.6 
9/16/12 8.873 25.6 7.0 132 238 32.7 1.2 26.0 6.8 2 2 0.1 5.2 
9/17/12 8.605 26.2 7.2 128 272 
 
1.3 26.5 7.0 2 2 
 
5.6 
9/18/12 8.620 25.7 7.3 148 184 
 
1.3 26.1 7.0 2 2 0.6 5.9 
9/19/12 8.432 25.5 7.2 144 230 
 
1.2 26.2 7.0 2 2 
 
5.7 
9/20/12 8.688 25.8 7.3 160 218 37.2 1.3 26.3 7.1 2 2 0.2 5.8 
9/21/12 8.504 25.7 7.2 
   
1.4 26.6 7.0 
   
5.8 
9/22/12 9.011 25.7 7.3 
   
1.3 27.0 7.0 
   
5.7 
9/23/12 8.680 25.8 7.0 176 232 33.8 1.3 26.5 6.7 3 2 0.0 5.4 
9/24/12 8.652 25.6 7.2 120 239 
 
1.1 26.6 7.0 4 2 
 
5.5 
9/25/12 8.706 25.8 7.2 140 224 
 
1.2 26.4 7.0 7 4 0.6 5.5 
9/26/12 8.942 25.7 7.2 192 258 
 
1.0 26.7 7.0 9 5 
 
5.3 
9/27/12 11.251 25.0 7.3 140 292 29.6 1.4 25.4 6.8 12 2 0.7 5.6 
9/28/12 8.970 25.6 7.4 
   
1.1 26.4 7.1 
   
5.4 
9/29/12 10.029 24.7 7.3 
   
1.0 25.5 7.1 
   
5.3 
9/30/12 10.818 24.1 7.3 124 200 32.6 1.1 25.4 7.0 10 2 0.6 5.0 
158 
10/1/12 8.761 25.3 7.4 132 236 
 
1.0 25.6 7.2 9 2 
 
5.4 
10/2/12 8.635 25.1 7.5 128 203 
 
1.2 25.0 7.1 6 4 0.7 5.5 
10/3/12 8.940 24.9 7.5 188 282 
 
1.3 25.5 7.1 8 6 
 
5.4 
10/4/12 8.808 24.8 7.5 192 197 32.4 1.2 25.1 7.0 8 2 0.4 5.5 
10/5/12 8.478 24.6 7.4 
   
1.1 23.9 7.1 
   
5.6 
10/6/12 8.554 23.8 7.5 
   
1.6 23.0 7.2 
   
5.6 
10/7/12 8.598 23.9 7.3 148 247 30.5 1.3 23.2 7.0 11 5 0.4 5.0 
10/8/12 8.504 23.7 7.4 124 267 
 
1.2 23.1 7.1 12 7 
 
5.5 
10/9/12 8.788 23.9 7.5 148 289 
 
1.4 23.7 7.1 12 7 0.4 5.4 
10/10/12 8.469 23.7 7.5 152 239 
 
1.3 23.5 7.0 9 7 
 
5.6 
10/11/12 8.944 24.1 7.4 144 266 26.2 1.3 23.9 7.0 8 8 0.3 5.6 
10/12/12 8.301 24.2 7.3 
   
1.3 24.6 7.1 
   
5.6 
10/13/12 8.695 23.7 7.4 
   
1.2 24.2 7.3 
   
5.5 
10/14/12 8.692 24.1 7.4 144 245 26.0 1.4 24.1 7.0 5 3 0.2 5.6 
10/15/12 8.562 23.5 7.4 144 237 
 
1.4 24.2 7.0 4 3 
 
5.8 
10/16/12 9.105 24.5 7.5 164 304 
 
1.3 24.2 7.1 6 5 0.5 5.9 
10/17/12 8.671 23.7 7.5 196 261 
 
1.5 24.2 7.1 2 3 
 
5.8 
10/18/12 8.729 23.7 7.5 172 228 40.3 1.5 23.0 7.0 6 3 0.2 6.0 
10/19/12 8.367 23.2 7.5 
   
1.5 23.0 7.1 
   
5.8 
10/20/12 8.950 23.5 7.4 
   
1.5 23.7 7.1 
   
5.8 
10/21/12 9.277 24.2 7.3 148 219 30.2 1.4 25.1 7.0 5 3 0.4 5.7 
10/22/12 8.826 23.9 7.5 164 247 
 
1.3 24.3 7.3 5 3 
 
5.7 
10/23/12 9.086 24.0 7.5 184 248 
 
1.3 24.2 7.3 4 3 0.3 5.7 
10/24/12 8.718 24.0 7.4 148 247 
 
1.2 24.3 7.0 5 3 
 
5.5 
10/25/12 8.760 23.6 7.5 172 232 28.9 1.1 23.1 7.3 4 3 0.4 5.7 
10/26/12 8.233 23.0 7.5 
   
1.2 21.4 7.2 
   
5.9 
10/27/12 8.990 22.8 7.4 
   
1.3 21.5 7.1 
   
5.6 
10/28/12 8.813 23.0 7.4 144 217 32.7 1.3 22.8 7.0 4 2 1.1 5.5 
10/29/12 8.352 22.7 7.4 184 232 
 
1.1 22.3 7.1 4 2 
 
5.8 
10/30/12 8.602 23.0 7.4 168 291 
 
1.3 22.6 7.0 3 2 0.2 5.8 
10/31/12 7.953 23.1 7.5 136 250 
 
1.2 22.8 7.3 3 3 
 
6.0 
11/1/12 8.356 23.1 7.5 148 220 35.5 1.6 23.0 7.3 5 3 0.2 6.0 
11/2/12 8.184 23.3 7.5 
   
2.0 23.5 7.3 
   
6.5 
11/3/12 8.435 23.4 7.5 
   
1.5 22.5 7.1 
   
6.1 
11/4/12 8.430 23.2 7.3 164 241 29.5 2.3 22.9 7.0 4 3 0.1 7.0 
11/5/12 8.322 23.0 7.5 152 242 
 
1.8 22.4 7.3 4 4 
 
6.5 
11/6/12 8.329 23.0 7.5 140 249 
 
1.8 22.6 7.3 4 4 0.4 6.6 
11/7/12 8.196 22.5 7.5 144 205 
 
2.3 22.7 7.0 5 3 
 
7.0 
11/8/12 8.172 22.8 7.5 136 202 33.8 1.4 22.4 7.2 6 4 0.3 5.2 
11/9/12 8.465 22.8 7.4 
   
1.3 23.2 7.3 
   
5.8 
159 
11/10/12 8.924 22.8 7.5 
   
1.2 23.0 7.3 
   
5.6 
11/11/12 10.523 21.1 7.3 148 220 27.9 1.3 21.5 7.0 11 4 0.3 5.0 
11/12/12 8.750 21.5 7.6 128 222 
 
1.3 21.0 7.1 10 4 
 
6.0 
11/13/12 8.871 21.9 7.6 280 218 
 
1.3 21.8 7.3 7 4 1.6 5.8 
11/14/12 8.400 21.8 7.6 160 221 
 
1.4 21.2 7.2 8 5 
 
6.1 
11/15/12 8.598 21.9 7.5 168 234 33.9 1.1 21.2 7.3 6 4 0.1 6.0 
11/16/12 8.136 21.7 7.5 
   
1.5 21.3 7.1 
   
6.3 
11/17/12 8.488 21.2 7.3 
   
1.3 21.0 7.0 
   
6.3 
11/18/12 8.637 21.4 7.4 188 265 28.6 1.5 21.2 7.0 5 2 0.1 5.7 
11/19/12 8.272 21.8 7.5 164 239 
 
1.2 21.5 7.4 3 3 
 
6.0 
11/20/12 8.298 22.0 7.5 136 234 
 
1.2 22.2 7.3 3 2 0.3 6.0 
11/21/12 8.064 21.4 7.5 168 262 
 
1.4 21.8 7.3 3 2 
 
6.2 
11/22/12 7.575 21.3 7.4 128 234 25.8 1.2 21.6 7.3 3 3 0.3 6.1 
11/23/12 7.232 21.0 7.4 
   
1.4 20.5 7.2 
   
5.5 
11/24/12 8.234 20.8 7.5 
   
1.3 20.0 7.1 
   
5.2 
11/25/12 8.437 21.2 7.4 172 242 29.8 1.5 20.8 7.0 4 3 0.5 5.9 
11/26/12 8.181 20.5 7.5 152 265 
 
1.2 19.8 7.1 3 3 
 
6.4 
11/27/12 8.393 20.9 7.5 116 229 
 
1.7 19.5 7.5 4 3 0.1 6.3 
11/28/12 8.296 20.8 7.5 140 259 
 
0.8 19.9 7.3 6 3 
 
6.4 
11/29/12 8.356 22.0 7.5 240 233 31.3 1.2 20.0 7.2 4 3 0.1 6.2 
11/30/12 8.263 21.0 7.4 
   
0.9 20.8 7.3 
   
6.2 
12/1/12 8.482 20.8 7.5 
   
0.6 21.0 7.4 
   
6.1 
12/2/12 8.298 21.2 7.3 124 229 30.7 0.8 21.5 7.0 4 3 0.6 5.4 
12/3/12 8.617 20.7 7.4 140 211 
 
0.5 21.2 7.1 3 3 
 
6.1 
12/4/12 8.178 21.0 7.5 152 235 
 
0.4 20.7 7.1 2 2 0.1 6.1 
12/5/12 8.253 20.9 7.4 216 233 
 
0.6 20.3 7.1 3 2 
 
6.1 
12/6/12 8.278 21.0 7.6 160 239 31.7 0.6 20.7 7.3 3 2 0.1 6.0 
12/7/12 8.300 20.2 7.6 
   
0.4 20.2 7.3 
   
6.0 
12/8/12 8.491 20.2 7.5 
   
0.8 20.2 7.1 
   
6.0 
12/9/12 8.397 20.0 7.5 140 206 32.3 0.5 19.9 7.1 4 3 0.1 5.2 
12/10/12 8.595 20.0 7.5 200 223 
 
0.5 18.3 7.4 3 3 
 
6.3 
12/11/12 8.474 19.9 7.6 120 231 
 
0.7 18.7 7.4 3 2 0.1 6.2 
12/12/12 8.524 19.8 7.5 168 239 
 
0.7 18.8 7.2 3 3 
 
6.1 
12/13/12 8.342 20.0 7.5 160 254 28.1 0.4 18.9 7.1 4 3 0.0 6.4 
12/14/12 8.345 19.9 7.4 
   
0.4 18.9 7.1 
   
6.1 
12/15/12 8.571 19.4 7.5 
   
1.3 19.0 7.1 
   
5.3 
12/16/12 7.987 20.0 7.3 136 206 25.8 0.9 20.0 7.0 4 3 0.1 5.6 
12/17/12 7.998 19.7 7.6 152 219 
 
0.7 19.3 7.1 4 3 
 
6.1 
12/18/12 7.724 19.9 7.5 148 204 
 
1.7 19.5 7.1 4 3 0.1 6.8 
12/19/12 7.932 19.8 7.5 124 212 
 




12/20/12 7.776 19.0 7.4 116 239 29.2 0.4 17.5 7.3 4 2 0.5 6.6 
12/21/12 7.623 18.8 7.4 
   
1.0 17.8 7.1 
   
6.1 
12/22/12 7.675 18.7 7.4 
   
1.0 18.2 7.2 
   
6.6 
12/23/12 7.258 19.0 8.5 120 208 30.3 0.6 18.3 7.1 4 3 0.1 6.3 
12/24/12 7.759 17.9 7.3 144 244 
 
0.9 17.3 7.1 4 3 
 
6.3 
12/25/12 7.489 17.0 7.5 156 239 
 
0.4 15.8 7.2 5 3 
 
6.5 
12/26/12 7.737 17.7 7.5 148 204 
 
1.0 15.3 7.2 4 3 
 
6.9 
12/27/12 8.399 17.4 7.5 140 211 30.2 0.8 15.4 7.2 4 3 0.4 6.7 
12/28/12 7.970 17.7 7.5 
   
1.1 16.3 7.1 
   
6.6 
12/29/12 7.956 17.1 7.5 
   
1.0 16.0 7.5 
   
6.3 
12/30/12 7.853 17.5 7.4 136 247 28.0 0.8 16.4 7.0 5 4 0.1 6.4 
12/31/12 9.318 16.2 7.3 148 211 
 
0.8 16.0 7.1 5 3 
 
6.7 
1/1/13 8.173 18.0 7.8 172 280 
 
0.8 16.0 7.0 6 6 0.5 5.5 
1/2/13 8.193 17.3 7.5 124 246 
 
0.4 16.4 7.2 5 2 
 
6.4 
1/3/13 8.037 17.3 7.6 164 239 29.6 0.8 16.5 7.2 5 2 0.4 6.5 
1/4/13 7.906 16.9 7.6 
   
0.8 16.4 7.2 
   
6.6 
1/5/13 7.888 16.0 7.4 
   
0.4 17.0 7.3 
   
5.7 
1/6/13 7.805 17.5 7.3 144 182 32.8 0.7 17.4 7.1 7 3 0.1 5.5 
1/7/13 8.153 17.2 7.6 136 202 
 
0.8 16.5 7.2 8 4 
 
6.5 
1/8/13 7.920 17.2 7.5 148 251 
 
0.8 16.6 7.1 8 4 0.2 6.5 
1/9/13 8.229 17.3 7.6 168 238 
 
0.9 17.0 7.1 10 4 
 
6.3 
1/10/13 9.778 17.2 7.5 112 211 24.2 0.4 17.8 7.3 6 4 0.3 6.4 
1/11/13 8.588 17.0 7.5 
   
0.6 17.0 7.3 
   
6.0 
1/12/13 8.377 17.0 7.4 
   
0.5 16.0 7.0 
   
6.1 
1/13/13 8.471 17.0 7.5 148 240 29.7 0.8 15.4 7.1 6 4 0.2 6.3 
1/14/13 8.395 16.5 7.6 152 227 
 
0.4 15.5 6.8 7 4 
 
6.6 
1/15/13 8.373 16.9 7.7 248 237 
 
0.9 15.7 7.5 7 5 0.3 6.2 
1/16/13 8.529 17.1 7.7 136 248 
 
0.7 16.0 7.2 8 5 
 
6.4 
1/17/13 8.250 17.0 7.6 160 245 39.3 0.6 16.4 7.1 8 4 0.1 6.4 
1/18/13 8.480 17.0 7.7 
   
0.9 16.5 7.2 
   
6.4 
1/19/13 8.133 16.0 7.3 
   
1.4 17.0 7.1 
   
5.0 
1/20/13 8.007 17.5 7.5 132 246 32.7 0.4 17.9 7.0 8 4 0.2 5.3 
1/21/13 8.283 16.0 7.6 164 225 
 
0.5 16.0 7.0 10 4 
 
5.4 
1/22/13 8.258 17.1 7.7 204 258 
 
0.8 16.4 7.0 10 5 0.9 6.2 
1/23/13 8.254 17.5 7.6 148 237 
 
0.7 17.4 7.1 8 5 
 
6.3 
1/24/13 8.196 17.1 7.7 132 230 36.1 0.8 16.9 7.0 6 4 0.5 6.3 
1/25/13 8.144 16.7 7.6 
   
0.9 16.5 7.0 
   
6.4 
1/26/13 8.354 16.0 7.5 
   
0.5 16.0 7.1 
   
5.4 
1/27/13 8.441 17.2 7.5 144 232 27.3 0.7 17.7 7.0 7 4 0.4 5.7 
1/28/13 8.558 17.9 7.5 136 242 
 




1/29/13 8.917 17.8 7.6 240 377 
 
0.8 18.2 7.0 6 7 0.6 6.1 
1/30/13 8.404 17.3 7.7 140 256 
 
0.5 16.8 7.4 6 4 
 
6.4 
1/31/13 8.196 17.5 7.5 136 256 29.2 0.4 17.2 7.1 6 4 0.2 6.2 
2/1/13 8.192 16.9 7.5 
   
0.7 16.3 6.9 
   
6.5 
2/2/13 8.324 16.0 7.6 
   
0.9 17.0 6.9 
   
5.6 
2/3/13 8.413 17.5 7.4 148 228 29.8 0.4 17.5 7.0 7 5 0.3 5.3 
2/4/13 8.335 17.7 7.5 160 237 
 
0.8 17.8 6.9 6 4 
 
6.2 
2/5/13 8.174 18.0 7.6 148 259 
 
0.3 17.0 6.8 8 5 0.6 6.0 
2/6/13 8.289 17.0 7.6 168 239 
 
0.8 18.0 7.1 7 4 
 
5.6 
2/7/13 8.366 17.0 7.6 184 251 32.8 0.7 18.3 7.2 4 4 0.2 6.1 
2/8/13 8.059 17.2 7.6 
   
0.4 17.6 7.0 
   
6.3 
2/9/13 8.389 17.0 7.4 
   
0.4 16.5 7.3 
   
5.6 
2/10/13 8.370 17.5 7.5 144 254 24.1 1.8 17.9 6.9 5 3 0.4 6.1 
2/11/13 8.028 17.5 7.6 168 206 
 
1.3 17.0 6.8 5 3 
 
6.6 
2/12/13 10.104 16.5 7.5 236 251 
 
1.5 16.8 6.7 6 4 0.5 5.7 
2/13/13 8.910 16.8 7.7 144 219 
 
1.2 16.3 7.0 5 4 
 
6.6 
2/14/13 8.330 17.7 7.7 136 239 28.6 0.8 17.2 6.9 4 3 0.3 6.2 
2/15/13 8.241 17.0 7.6 
   
1.0 16.4 7.0 
   
6.5 
2/16/13 8.351 16.0 7.6 
   
0.9 17.0 7.2 
   
5.6 
2/17/13 8.250 17.0 7.5 128 238 24.9 1.2 18.0 7.3 14 5 0.3 6.2 
2/18/13 8.472 17.3 7.6 152 232 
 
0.9 17.1 6.8 7 3 
 
6.4 
2/19/13 8.277 17.1 7.5 152 261 
 
1.4 17.3 6.8 6 6 0.3 6.1 
2/20/13 10.676 15.8 7.3 168 203 
 
1.3 16.1 6.8 4 4 
 
6.2 
2/21/13 11.774 14.5 7.5 156 193 20.7 1.3 14.7 6.6 4 5 0.3 6.5 
2/22/13 9.166 16.0 7.6 
   
2.3 15.0 6.9 
   
6.4 
2/23/13 8.827 16.0 7.5 
   
3.6 15.0 7.1 
   
5.7 
2/24/13 8.743 16.5 7.5 124 177 24.4 1.4 16.0 6.6 4 4 1.0 6.5 
2/25/13 12.989 14.2 7.2 228 171 
 
1.3 16.1 6.9 6 5 
 
5.2 
2/26/13 10.122 15.6 7.7 144 155 
 
1.1 14.5 6.8 4 3 0.8 6.7 
2/27/13 9.440 16.2 7.7 140 173 
 
1.3 15.4 6.8 4 3 
 
6.5 
2/28/13 8.982 16.2 7.7 172 198 29.7 1.4 15.8 6.8 5 3 0.3 6.4 
3/1/13 8.775 16.1 7.6 
   
1.3 16.0 6.9 
   
6.6 
3/2/13 8.668 15.7 7.5 
   
1.6 15.7 6.6 
   
6.8 
3/3/13 8.799 16.0 7.6 96 196 29.5 1.9 17.0 7.0 5 4 0.2 6.5 
3/4/13 8.546 16.9 7.6 140 202 
 
1.3 17.1 6.9 5 4 
 
6.3 
3/5/13 8.682 16.4 7.6 120 225 
 
1.4 15.9 6.9 4 2 0.5 6.5 
3/6/13 8.606 16.3 7.6 140 239 
 
1.5 16.3 6.8 16 24 
 
6.5 
3/7/13 8.556 16.4 7.6 160 264 34.5 1.5 16.8 6.7 3 3 0.2 6.2 
3/8/13 8.592 16.9 7.6 
   
1.5 17.0 7.0 
   
6.3 
3/9/13 9.207 15.5 7.5 
   
1.4 17.0 6.7 
   
5.7 
162 
3/10/13 9.220 15.0 7.6 140 267 25.5 1.6 16.0 7.4 4 3 0.2 5.5 
3/11/13 8.673 16.4 7.7 124 190 
 
1.5 15.9 7.0 4 3 
 
6.2 
3/12/13 8.865 16.8 7.6 208 226 
 
1.4 16.6 6.9 5 3 1.7 6.3 
3/13/13 8.659 16.6 7.6 116 197 
 
1.5 17.1 6.9 4 3 
 
6.6 
3/14/13 8.389 17.0 7.5 148 190 31.6 1.6 17.7 7.0 3 3 0.1 6.5 
3/15/13 8.424 17.5 7.4 
   
1.3 18.3 7.0 
   
6.5 
3/16/13 7.979 17.2 7.4 
   
1.3 18.5 6.7 
   
6.5 
3/17/13 7.693 16.0 7.6 136 182 32.2 2.3 17.0 7.1 3 2 0.2 6.5 
3/18/13 7.709 16.3 7.4 140 226 
 
1.5 16.8 6.9 4 2 
 
6.4 
3/19/13 7.743 16.8 7.4 128 207 
 
1.3 17.2 7.0 11 14 1.9 6.3 
3/20/13 7.550 16.7 7.5 104 256 
 
1.5 17.0 7.0 3 2 
 
6.6 
3/21/13 7.824 16.4 7.3 156 227 38.7 1.3 16.2 7.0 3 2 0.2 6.5 
3/22/13 7.730 16.3 7.5 
   
1.6 16.3 7.1 
   
6.3 
3/23/13 7.918 16.1 7.3 
   
1.4 16.1 6.9 
   
5.4 
3/24/13 8.217 16.0 7.5 192 267 36.8 1.8 15.5 7.1 4 3 0.2 5.2 
3/25/13 8.672 16.7 7.6 124 245 
 
1.4 15.9 7.0 5 3 
 
6.4 
3/26/13 8.460 16.8 7.5 168 233 
 
1.3 16.5 6.9 5 2 0.2 6.6 
3/27/13 8.567 17.0 7.6 140 231 
 
1.3 16.4 6.9 5 3 
 
6.6 
3/28/13 8.294 17.2 7.5 204 282 30.7 1.4 17.5 6.8 5 3 0.3 6.5 
3/29/13 8.216 17.4 7.4 
   
1.3 17.8 6.9 
   
6.3 
3/30/13 8.220 16.1 7.2 
   
1.6 16.9 6.8 
   
5.7 
3/31/13 9.373 16.5 7.4 172 209 29.1 1.5 16.3 6.7 6 3 0.5 5.9 
4/1/13 8.630 17.8 7.5 152 220 
 
1.3 18.2 6.9 6 2 
 
6.4 
4/2/13 12.731 16.2 7.5 188 178 
 
1.2 16.4 6.9 7 4 1.3 6.3 
4/3/13 18.473 14.8 7.6 120 172 
 
1.7 14.9 6.8 8 5 
 
6.7 
4/4/13 15.595 15.0 7.6 100 173 26.2 1.5 13.9 6.8 5 4 0.8 7.1 
4/5/13 10.770 16.4 7.7 
   
1.5 16.3 7.0 
   
6.7 
4/6/13 10.124 15.4 7.6 
   
1.5 16.0 7.0 
   
6.4 
4/7/13 9.999 16.7 7.5 156 253 26.6 1.6 17.5 6.9 4 3 0.7 6.4 
4/8/13 9.858 17.9 7.5 124 243 
 
1.1 18.8 7.1 4 2 
 
6.1 
4/9/13 9.592 18.0 7.6 200 188 
 
1.2 19.0 7.1 6 3 0.8 6.1 
4/10/13 15.726 13.8 7.4 156 162 
 
1.8 15.7 7.0 7 5 
 
5.6 
4/11/13 11.868 16.3 7.7 100 303 41.5 1.2 15.4 7.0 4 3 0.4 6.7 
4/12/13 10.251 16.8 7.6 
   
1.0 16.6 7.1 
   
6.6 
4/13/13 9.950 15.9 7.5 
   
1.3 15.6 6.9 
   
6.1 
4/14/13 9.870 16.2 7.5 136 209 22.8 1.3 16.0 6.9 3 3 0.4 6.2 
4/15/13 9.661 17.9 7.5 108 203 
 
1.2 18.8 7.1 3 3 
 
6.4 
4/16/13 9.506 17.5 7.5 152 254 
 
1.0 17.9 7.0 3 2 1.0 6.1 
4/17/13 10.715 18.2 7.4 156 158 
 
1.1 18.8 6.9 8 6 
 
6.3 
4/18/13 21.197 16.1 7.7 136 139 24.2 2.0 15.3 6.9 5 6 0.6 6.4 
163 
4/19/13 11.724 17.0 7.6 
   
1.3 16.5 7.0 
   
6.7 
4/20/13 10.487 17.0 7.6 
   
1.5 18.1 6.9 
   
5.9 
4/21/13 9.965 17.1 7.5 112 158 21.7 1.3 17.7 7.0 2 3 0.3 6.6 
4/22/13 10.290 17.9 7.5 116 244 
 
1.1 18.8 7.0 3 3 
 
6.5 
4/23/13 10.022 17.1 7.6 124 242 
 
1.2 16.7 7.0 3 2 0.5 6.4 
4/24/13 9.707 17.5 7.5 152 223 
 
1.2 17.3 7.5 3 2 
 
6.7 
4/25/13 9.611 18.0 7.5 160 227 24.3 1.1 18.2 7.0 2 2 0.3 6.5 
4/26/13 9.818 17.6 7.4 
   
1.1 17.8 7.0 
   
6.4 
4/27/13 12.328 16.5 7.5 
   
1.4 17.0 6.9 
   
5.9 
4/28/13 10.298 16.5 7.5 132 173 18.7 1.3 19.5 6.9 3 3 0.5 6.3 
4/29/13 10.051 18.8 7.5 160 184 
 
1.2 19.9 7.0 4 3 
 
6.3 
4/30/13 9.879 19.5 7.5 148 176 
 
1.9 20.5 7.1 4 3 0.9 6.3 
5/1/13 9.874 19.0 7.4 164 208 
 
1.0 20.6 6.9 4 5 
 
6.4 
5/2/13 8.574 17.4 7.6 132 212 20.8 1.2 17.3 7.1 3 6 0.7 6.2 
5/3/13 9.405 18.3 7.3 
   
1.0 17.8 6.9 
   
6.6 
5/4/13 9.443 16.9 7.4 
   
1.5 17.0 7.0 
   
6.5 
5/5/13 9.395 17.0 7.5 140 212 24.9 1.2 17.5 7.0 3 3 0.1 5.5 
5/6/13 9.258 18.4 7.4 116 176 
 
1.0 19.3 7.0 4 3 
 
6.4 
5/7/13 9.534 19.2 7.4 132 207 
 
1.1 20.1 6.9 4 5 1.7 6.3 
5/8/13 10.349 18.0 7.4 280 196 
 
0.9 21.0 7.0 6 6 
 
6.2 
5/9/13 12.995 18.8 7.6 168 194 19.7 1.2 19.4 6.8 5 7 2.3 6.2 
5/10/13 10.960 19.2 7.5 
   
1.1 19.9 6.9 
   
6.4 
5/11/13 10.166 19.6 7.4 
   
1.2 20.5 6.9 
   
6.8 
5/12/13 9.446 19.5 7.4 112 203 23.1 1.1 20.6 6.9 3 3 1.2 6.1 
5/13/13 9.703 19.3 7.3 132 178 
 
1.2 20.3 6.9 3 3 
 
6.3 
5/14/13 9.522 19.3 7.4 128 171 
 
1.1 20.9 6.9 3 3 0.9 6.3 
5/15/13 10.359 19.4 7.4 156 157 
 
0.9 20.6 6.9 3 3 
 
6.2 
5/16/13 10.480 18.9 7.4 216 216 24.6 1.2 19.8 6.9 3 3 0.6 6.0 
5/17/13 9.795 19.3 7.4 
   
1.1 20.0 6.9 
   
6.1 
5/18/13 9.883 19.6 7.4 
   
1.1 21.7 6.9 
   
6.4 
5/19/13 12.273 19.5 7.4 264 172 23.1 1.1 21.7 6.9 3 3 0.7 6.2 
5/20/13 10.970 19.9 7.4 128 132 
 
1.0 21.4 6.8 3 3 
 
6.2 
5/21/13 12.313 19.0 7.5 132 137 
 
1.2 19.9 6.9 4 3 0.8 6.3 
5/22/13 11.349 18.4 7.5 124 119 
 
0.8 19.2 6.9 3 2 
 
6.3 
5/23/13 16.890 17.3 7.1 212 140 30.6 1.0 18.8 6.9 8 5 0.7 5.1 
5/24/13 12.487 18.2 7.5 
   
1.1 19.2 7.0 
   
6.5 
5/25/13 11.162 17.9 7.4 
   
1.2 19.5 7.0 
   
6.3 
5/26/13 10.583 17.3 7.5 104 148 24.8 1.1 18.0 7.0 3 3 0.2 6.3 
5/27/13 11.111 18.0 7.4 128 170 
 
1.4 19.3 7.1 4 2 
 
6.2 
5/28/13 10.470 18.7 7.3 136 169 
 
1.3 20.2 6.9 3 2 0.6 6.0 
164 
5/29/13 10.671 18.5 7.3 144 161 
 
1.4 20.0 6.9 4 2 
 
6.2 
5/30/13 10.965 19.0 7.4 152 171 25.8 1.4 20.3 7.0 5 3 0.6 6.3 
5/31/13 12.052 19.1 7.4 
   
1.3 20.6 6.9 
   
6.3 
6/1/13 26.641 16.5 7.3 
   
2.9 18.0 6.9 
   
6.0 
6/2/13 13.584 17.5 7.4 84 119 15.3 1.6 19.5 7.1 14 4 0.3 6.3 
6/3/13 12.014 18.5 7.5 124 133 
 
1.5 19.7 6.9 3 3 
 
6.9 
6/4/13 19.054 19.0 7.3 140 87 
 
2.7 19.5 7.1 5 4 0.4 5.9 
6/5/13 14.720 19.2 7.4 120 128 
 
1.1 20.0 7.0 3 2 
 
5.5 
6/6/13 12.728 19.1 7.4 124 198 17.5 1.2 20.1 7.1 2 2 0.3 6.1 
6/7/13 11.391 19.6 7.4 
   
1.4 20.7 7.1 
   
6.2 
6/8/13 11.091 19.4 7.3 
   
1.2 21.2 7.0 
   
6.1 
6/9/13 11.238 20.0 7.4 112 132 19.9 1.3 21.3 7.0 3 2 0.1 5.9 
6/10/13 11.206 20.0 7.3 120 143 
 
1.0 21.4 7.1 3 2 
 
6.2 
6/11/13 10.961 20.2 7.3 116 137 
 
1.0 21.9 7.1 3 3 0.4 6.2 
6/12/13 10.559 20.0 7.3 140 151 
 
1.0 22.2 7.1 2 2 
 
6.0 
6/13/13 10.256 20.4 7.3 140 173 18.6 1.1 22.7 7.0 2 2 0.3 5.9 
6/14/13 10.018 20.6 7.3 
   
1.1 22.9 6.9 
   
6.0 
6/15/13 10.794 20.0 7.1 
   
1.1 21.6 6.9 
   
6.1 
6/16/13 10.035 20.5 7.2 164 166 18.3 1.0 22.5 6.7 2 3 0.6 6.2 
6/17/13 13.555 20.3 7.2 128 127 
 
1.1 21.8 6.9 2 2 
 
5.9 
6/18/13 10.600 20.7 7.3 132 275 
 
0.8 22.0 6.9 2 4 0.2 6.1 
6/19/13 10.499 20.6 7.3 180 126 
 
1.0 22.3 7.0 1 2 
 
6.0 
6/20/13 10.507 21.2 7.3 148 153 20.5 1.0 22.5 7.1 2 2 0.3 6.1 
6/21/13 10.102 21.2 7.3 
   
0.9 23.4 7.1 
   
6.3 
6/22/13 9.921 21.2 7.2 
   
1.0 23.2 7.1 
   
6.1 
6/23/13 9.742 21.5 7.2 144 174 17.7 1.1 23.1 7.1 2 2 0.1 6.4 
6/24/13 9.951 21.3 7.2 128 154 
 
1.0 23.1 7.0 3 2 
 
6.1 
6/25/13 10.031 21.0 7.2 152 156 
 
1.1 23.0 7.0 3 2 0.3 6.1 
6/26/13 10.086 21.2 7.2 140 160 
 
0.9 23.1 7.1 3 3 
 
6.0 
6/27/13 9.951 21.4 7.2 144 175 18.5 1.0 23.8 7.0 3 3 0.2 6.1 
6/28/13 9.717 21.6 7.3 
   
1.2 23.8 7.1 
   
6.1 
6/29/13 9.545 21.5 7.1 
   
1.2 23.4 7.0 
   
6.6 
6/30/13 9.117 21.5 7.1 156 132 26.2 1.2 23.2 7.0 3 2 0.1 6.0 









7/2/13 9.158 19.5 7.1 152 104 
 
0.8 20.2 7.0 2 3 0.2 5.8 
7/3/13 8.865 21.6 7.1 124 133 
 
0.8 23.0 7.1 2 2 
 
5.1 
7/4/13 8.407 21.2 7.2 132 152 17.5 1.1 23.4 7.0 1 2 0.2 5.8 
7/5/13 8.633 21.3 7.2 128 
  
1.1 22.8 7.0 2 
  
5.7 
7/6/13 9.079 22.0 7.2 
   
1.0 23.2 7.0 
   
5.8 
7/7/13 8.490 22.0 7.1 116 122 31.9 0.9 24.8 7.0 2 2 0.1 5.8 
165 
7/8/13 9.532 22.3 7.0 152 130 
 
0.9 24.1 6.9 2 2 
 
5.9 
7/9/13 9.503 22.3 7.0 136 185 
 
0.6 24.3 6.9 2 2 0.1 5.9 
7/10/13 9.285 22.6 7.2 120 127 
 
1.0 24.8 6.9 2 2 
 
5.7 
7/11/13 9.154 22.2 7.1 128 152 28.5 1.0 24.3 6.9 2 2 0.1 5.6 
7/12/13 9.221 22.7 7.0 
   
0.8 24.4 6.9 
   
5.7 
7/13/13 9.002 22.8 7.1 
   
0.9 24.2 6.9 
   
5.7 
7/14/13 11.575 23.3 6.9 272 132 24.1 0.8 24.5 6.9 2 3 0.2 5.7 
7/15/13 14.467 21.3 6.8 296 170 
 
1.6 22.1 6.8 5 3 
 
5.5 
7/16/13 11.535 21.8 7.2 136 103 
 
1.4 22.6 6.9 3 2 0.3 6.2 
7/17/13 14.980 22.0 7.2 140 109 
 
1.5 23.0 7.0 3 2 
 
6.1 
7/18/13 11.424 22.0 7.2 144 176 20.5 1.6 23.3 7.0 2 2 0.2 6.2 
7/19/13 10.432 22.4 7.2 
   
1.5 23.8 7.1 
   
6.0 
7/20/13 10.153 22.5 7.2 
   
1.3 24.5 7.1 
   
6.0 
7/21/13 9.873 24.5 7.2 140 124 24.6 1.3 25.5 7.1 1 3 0.3 6.1 
7/22/13 10.297 22.3 7.1 112 160 
 
1.0 24.4 7.1 2 2 
 
5.8 
7/23/13 10.028 23.0 7.2 96 59 
 
1.6 24.5 6.9 2 2 0.4 5.5 
7/24/13 11.020 22.5 7.0 152 168 
 
1.2 24.0 6.8 1 2 
 
5.8 
7/25/13 9.985 22.3 7.2 216 155 27.4 1.0 24.4 7.0 3 2 0.9 5.8 
7/26/13 23.781 21.3 6.8 
   
2.4 22.2 6.7 
   
5.1 
7/27/13 14.430 24.0 7.1 
   
1.2 25.1 7.0 
   
5.9 
7/28/13 12.932 24.9 7.4 88 110 23.7 1.1 25.3 7.1 2 2 0.3 5.7 
7/29/13 13.398 22.5 7.3 104 103 
 
1.2 23.7 7.1 2 2 
 
5.9 
7/30/13 14.008 22.7 7.2 92 93 
 
1.1 24.0 7.0 2 2 0.8 6.1 
7/31/13 11.882 22.6 7.3 92 168 
 
0.9 24.5 7.0 2 2 
 
5.9 
8/1/13 11.393 23.0 7.3 108 195 20.5 1.2 24.3 7.0 2 2 0.2 6.0 
8/2/13 10.851 23.2 7.2 
   
0.9 24.8 7.0 
   
5.9 
8/3/13 10.509 23.1 7.2 
   
1.0 24.8 6.9 
   
5.9 
8/4/13 10.279 22.5 7.1 116 176 25.1 1.1 24.9 6.9 2 2 0.2 6.0 
8/5/13 10.767 23.1 7.1 124 195 
 
1.0 24.8 7.0 2 2 
 
6.0 
8/6/13 10.392 23.3 7.1 132 211 
 
1.0 25.1 7.0 3 4 0.4 5.7 
8/7/13 10.293 23.1 7.1 140 198 
 
1.0 24.9 7.0 3 3 
 
5.5 
8/8/13 10.403 23.0 7.1 196 243 20.8 0.9 24.3 6.9 3 2 0.1 5.7 
8/9/13 13.234 23.1 7.0 
   
1.2 24.2 6.8 
   
5.9 
8/10/13 10.410 23.3 7.2 
   
1.3 24.2 6.9 
   
5.9 
8/11/13 10.185 23.5 7.1 108 191 24.3 1.1 24.6 7.0 2 2 1.6 5.9 
8/12/13 10.500 23.3 7.1 104 199 
 
1.1 24.7 7.0 1 2 
 
5.6 
8/13/13 13.672 22.7 6.9 176 181 
 
1.1 23.8 6.9 2 2 0.7 5.2 
8/14/13 11.269 23.0 7.2 108 151 
 
1.1 23.7 6.9 2 2 
 
5.8 
8/15/13 10.694 22.6 7.2 124 198 22.1 1.1 23.8 7.0 2 2 0.5 5.9 
8/16/13 12.756 22.5 7.3 
   
1.2 23.9 7.0 
   
5.7 
166 
8/17/13 11.270 22.5 7.2 
   
1.2 24.0 7.0 
   
5.9 
8/18/13 11.061 23.0 7.2 104 238 23.3 1.1 24.5 7.0 2 2 0.3 5.9 
8/19/13 11.315 22.8 7.2 112 206 
 
1.1 23.9 7.0 2 2 
 
5.9 
8/20/13 10.912 22.9 7.2 120 189 
 
1.0 24.3 7.0 2 3 0.3 5.9 
8/21/13 10.612 23.2 7.2 120 198 
 
0.8 24.5 7.0 2 2 
 
5.9 
8/22/13 10.437 23.0 7.2 132 203 19.0 0.8 24.5 6.7 2 2 0.2 5.9 
8/23/13 10.424 23.2 7.2 
   
0.9 24.8 7.0 
   
5.8 
8/24/13 10.425 23.5 7.2 
   
1.0 25.0 7.0 
   
6.0 
8/25/13 10.490 23.5 7.2 112 216 24.9 1.0 25.2 7.0 2 2 0.5 5.8 
8/26/13 10.506 23.3 7.1 148 258 
 
1.1 24.8 6.9 3 2 
 
5.9 
8/27/13 10.385 23.0 7.2 140 221 
 
0.9 24.7 7.0 3 2 0.5 5.8 
8/28/13 10.330 23.2 7.2 200 212 
 
0.8 24.5 7.0 3 3 
 
5.7 
8/29/13 10.108 23.2 7.2 136 222 19.8 0.8 24.6 7.1 3 2 0.4 5.6 
8/30/13 10.058 23.3 7.1 
   
1.6 25.0 7.0 
   
5.9 
8/31/13 10.119 23.8 7.3 
   
1.3 24.6 7.0 
   
5.8 
9/1/13 9.622 23.7 7.3 140 341 27.3 1.3 24.5 7.0 2 2 0.1 5.9 
9/2/13 10.596 23.8 7.2 144 218 
 
1.2 24.3 7.0 3 2 
 
5.8 
9/3/13 9.970 23.1 7.2 140 235 
 
1.2 24.2 6.9 2 3 0.5 5.2 
9/4/13 9.760 23.5 7.1 128 258 
 
0.7 24.7 7.0 3 2 
 
5.1 
9/5/13 9.710 23.2 7.2 152 261 14.4 1.0 24.6 6.9 2 2 0.3 5.6 
9/6/13 9.627 23.4 7.2 
   
0.9 24.9 7.0 
   
5.6 
9/7/13 9.513 23.0 7.1 
   
1.3 25.0 6.8 
   
6.2 
9/8/13 10.382 24.0 7.2 128 213 27.0 1.1 25.4 6.9 4 4 0.8 5.9 
9/9/13 9.670 23.5 7.1 128 232 
 
0.9 24.9 6.9 5 3 
 
5.8 
9/10/13 9.692 23.3 7.2 156 230 
 
0.9 24.8 7.0 4 3 0.3 5.6 
9/11/13 9.681 23.5 7.2 136 218 
 
0.9 25.0 6.9 4 4 
 
5.9 
9/12/13 9.853 23.4 7.2 180 244 11.8 0.9 25.1 6.9 4 3 0.2 5.5 
9/13/13 9.845 23.6 7.2 
   
0.8 24.8 6.9 
   
5.5 
9/14/13 9.551 25.5 7.2 
   
1.1 26.3 6.8 
   
5.7 
9/15/13 9.653 23.0 7.2 144 245 28.7 0.7 24.0 6.9 3 3 0.1 5.6 
9/16/13 9.609 23.2 7.2 148 251 
 
1.1 24.2 6.7 2 2 
 
6.6 
9/17/13 9.767 23.0 7.2 136 186 
 
1.2 24.5 6.7 3 2 0.2 6.1 
9/18/13 9.642 23.4 7.2 160 249 
 
0.8 24.7 7.0 3 2 
 
5.7 
9/19/13 10.796 23.2 7.2 260 249 25.4 1.1 24.5 7.0 3 2 0.4 5.6 
9/20/13 9.885 22.8 7.3 
   
0.9 23.2 6.8 
   
5.6 
9/21/13 9.114 24.5 7.2 
   
1.1 26.2 6.9 
   
5.9 
9/22/13 9.246 24.5 7.2 132 216 26.8 1.0 25.0 6.9 4 3 0.2 5.8 
9/23/13 9.606 22.4 7.2 144 274 
 
1.1 23.2 7.0 3 2 
 
5.7 
9/24/13 9.276 22.8 7.1 176 221 
 
1.0 23.3 7.0 2 2 0.1 5.7 
9/25/13 9.162 22.6 7.3 128 226 
 




9/26/13 9.500 22.8 7.2 188 257 24.5 0.8 23.9 7.0 3 2 0.3 5.8 
9/27/13 9.119 23.2 7.3 
   
0.6 23.8 7.0 
   
5.8 
9/28/13 12.131 23.2 6.5 
   
0.9 24.5 6.8 
   
5.8 
9/29/13 9.597 21.5 7.3 128 217 24.9 1.2 22.2 6.7 3 3 0.3 6.1 
9/30/13 9.492 22.2 7.2 132 239 
 
1.0 22.8 6.9 3 2 
 
5.8 
10/1/13 9.451 22.5 7.3 124 244 
 
1.0 23.3 6.9 2 2 0.4 6.0 
10/2/13 9.863 22.7 7.1 152 232 
 
0.8 23.4 6.9 3 2 
 
6.0 
10/3/13 9.639 22.4 7.2 136 229 17.6 1.2 23.7 6.8 2 2 0.1 6.0 
10/4/13 9.625 22.7 7.1 
   
1.0 23.8 6.9 
   
5.8 
10/5/13 10.599 20.4 7.2 
   
1.1 21.5 6.8 
   
5.1 
10/6/13 9.630 21.2 7.1 148 241 29.0 0.7 21.1 6.9 2 2 0.1 6.2 
10/7/13 9.312 21.6 7.3 196 254 
 
1.0 21.9 6.9 3 3 
 
5.7 
10/8/13 9.202 21.8 7.2 144 250 
 
0.9 22.0 6.8 2 2 0.3 5.7 
10/9/13 9.490 20.5 7.2 140 250 
 
1.0 21.0 6.9 2 2 
 
6.0 
10/10/13 9.172 20.9 7.1 136 248 27.2 1.0 21.3 6.9 3 3 0.2 5.8 
10/11/13 8.619 20.9 7.2 
   
1.0 21.4 7.0 
   
5.8 
10/12/13 8.254 20.1 7.2 
   
1.1 21.2 6.9 
   
5.9 
10/13/13 8.836 20.4 7.2 128 254 28.1 1.1 21.0 6.9 1 2 0.1 5.9 
10/14/13 11.234 20.0 7.2 152 222 
 
1.1 20.5 6.9 10 2 
 
5.9 
10/15/13 12.190 19.0 7.4 124 290 
 
1.3 19.0 6.9 2 7 0.1 6.3 
10/16/13 9.700 19.3 7.4 156 286 
 
0.9 18.8 6.9 2 4 
 
6.0 
10/17/13 9.375 19.2 7.4 124 303 22.2 1.0 19.0 6.9 2 6 0.2 6.2 
10/18/13 9.340 18.9 7.2 
   
1.2 19.1 6.9 
   
6.0 
10/19/13 9.030 18.5 7.3 
   
1.3 19.2 6.9 
   
6.2 
10/20/13 9.375 20.2 7.2 132 221 29.0 0.9 22.3 6.9 2 2 0.4 5.7 
10/21/13 11.442 18.0 7.2 144 212 
 
1.2 18.5 7.0 2 2 
 
6.1 
10/22/13 9.615 19.1 7.3 136 264 
 
1.1 18.8 7.0 2 2 0.4 6.2 
10/23/13 9.304 19.0 7.3 140 267 
 
1.0 18.9 7.0 3 2 
 
6.0 
10/24/13 9.246 18.9 7.3 140 284 34.3 0.9 18.8 7.0 2 4 0.6 6.0 
10/25/13 9.076 18.7 7.2 
   
1.1 18.1 6.9 
   
6.0 
10/26/13 9.966 17.3 7.1 
   
1.3 18.0 6.9 
   
6.1 
10/27/13 9.627 19.3 7.2 124 246 26.9 1.0 22.0 7.0 2 3 0.1 5.3 
10/28/13 9.595 18.6 7.3 132 248 
 
1.2 18.8 6.9 2 3 
 
5.8 
10/29/13 9.550 18.9 7.2 144 241 
 
1.1 19.3 6.9 2 2 0.4 5.9 
10/30/13 10.627 18.9 7.1 164 236 
 
0.7 19.4 7.0 2 2 
 
5.7 
10/31/13 10.842 18.0 7.3 120 185 35.4 1.2 18.2 6.8 6 8 0.2 5.9 
11/1/13 9.589 18.3 7.3 
   
1.0 18.1 7.0 
   
6.1 
11/2/13 9.180 17.6 7.3 
   
1.0 18.0 6.9 
   
6.1 
11/3/13 9.646 17.4 7.2 160 219 28.4 1.0 18.1 6.9 2 2 0.7 5.9 
11/4/13 9.646 17.9 7.3 152 249 
 




11/5/13 10.019 18.0 7.1 144 222 
 
1.0 17.8 6.9 5 5 0.3 6.0 
11/6/13 15.271 16.5 7.4 112 205 
 
1.2 16.0 6.8 4 3 
 
6.2 
11/7/13 10.061 17.8 7.5 148 262 27.6 1.5 16.8 6.8 3 2 0.3 6.3 
11/8/13 9.740 17.2 7.4 
   
1.7 16.7 6.9 
   
6.4 
11/9/13 9.457 16.8 7.3 
   
1.1 17.5 6.9 
   
6.1 
11/10/13 9.597 17.8 7.2 136 249 27.4 1.2 18.8 7.0 3 2 0.1 6.0 
11/11/13 9.456 17.2 7.3 120 219 
 
1.2 18.0 6.9 3 3 
 
6.1 
11/12/13 9.396 16.9 7.3 112 232 
 
1.6 15.9 7.0 6 17 0.6 6.4 
11/13/13 9.633 16.8 7.3 128 240 
 
1.1 16.0 7.0 4 3 
 
6.3 
11/14/13 9.668 16.9 7.3 188 289 22.3 1.1 15.9 7.0 4 2 0.8 6.4 
11/15/13 9.204 17.1 7.2 
   
1.3 16.8 7.0 
   
6.4 
11/16/13 9.780 17.6 7.3 
   
1.1 18.2 7.0 
   
6.3 
11/17/13 9.487 21.3 7.3 148 261 31.8 1.0 21.5 6.9 3 3 2.5 6.0 
11/18/13 9.147 21.3 7.3 160 234 
 
1.3 20.9 7.0 3 2 
 
6.1 
11/19/13 9.137 21.0 7.2 152 257 
 
1.0 20.7 7.0 4 3 0.9 6.2 
11/20/13 9.245 20.8 7.0 148 267 
 
1.1 20.3 7.0 5 4 
 
6.1 
11/21/13 9.231 21.1 7.3 160 238 30.5 0.9 21.2 6.9 5 2 0.7 5.3 
11/22/13 9.105 19.6 7.4 
   
1.1 18.1 7.0 
   
6.3 
11/23/13 9.699 18.2 7.3 
   
1.0 18.6 7.0 
   
6.4 
11/24/13 9.752 17.0 7.4 124 256 26.9 1.0 17.9 6.9 5 2 1.3 6.4 
11/25/13 9.957 19.4 7.3 148 246 
 
1.1 18.3 6.9 3 4 
 
6.2 
11/26/13 9.500 19.4 7.3 112 233 
 
1.2 18.4 7.0 4 2 1.4 6.4 
11/27/13 9.005 19.0 7.3 136 259 
 
1.3 18.3 6.9 4 2 
 
6.3 
11/28/13 8.221 19.0 7.3 116 239 25.6 1.1 18.5 6.9 3 2 0.4 6.3 
11/29/13 7.971 18.7 7.3 
   
1.5 18.2 6.8 
   
6.6 
11/30/13 8.566 19.0 7.2 
   
1.1 18.5 6.8 
   
6.4 
12/1/13 8.917 18.0 7.2 136 264 29.1 1.2 18.3 6.8 4 2 0.7 6.4 
12/2/13 9.277 19.3 7.3 164 293 
 
1.4 19.0 6.8 4 2 
 
6.2 
12/3/13 9.196 19.0 7.2 184 268 
 
1.1 19.2 6.9 4 3 0.6 6.3 
12/4/13 9.101 19.4 7.3 188 273 
 
1.5 18.4 7.0 4 2 
 
6.3 
12/5/13 9.407 18.1 7.3 156 272 27.5 1.2 16.3 6.9 4 2 0.6 6.6 
12/6/13 9.555 17.4 7.3 
   
1.4 15.7 7.0 
   
6.5 
12/7/13 9.835 17.4 7.4 
   
1.3 15.9 6.9 
   
6.5 
12/8/13 10.236 17.0 7.3 144 263 31.2 1.3 16.2 6.9 4 3 0.5 6.5 
12/9/13 9.894 17.6 7.2 152 278 
 
1.2 16.0 6.9 4 2 
 
6.5 
12/10/13 9.905 18.1 7.3 156 261 
 
1.5 15.9 7.0 5 5 0.5 6.6 
12/11/13 9.662 17.3 7.3 132 269 
 
1.3 17.0 6.9 4 2 
 
6.6 
12/12/13 9.702 18.0 7.3 140 283 23.0 1.2 16.9 7.0 4 2 0.4 6.8 
12/13/13 9.697 18.2 7.2 
   
1.0 17.3 7.0 
   
6.2 
12/14/13 9.432 17.3 7.2 
   
1.2 16.8 7.0 
   
6.6 
169 
12/15/13 9.192 18.4 7.3 156 272 26.3 1.1 17.5 7.0 3 2 0.4 6.6 
12/16/13 8.826 18.5 7.2 123 283 
 
1.4 18.3 6.9 3 2 
 
6.6 
12/17/13 8.814 18.6 7.3 124 254 
 
1.5 18.4 7.0 3 3 0.5 6.6 
12/18/13 8.780 18.5 7.4 148 250 
 
1.5 18.5 7.0 3 3 
 
6.5 
12/19/13 8.743 18.5 7.3 244 284 27.8 1.2 18.3 7.1 3 2 0.3 6.7 
12/20/13 8.789 17.7 7.2 
   
1.4 16.9 7.0 
   
6.5 
12/21/13 15.215 15.0 7.2 
   
1.7 15.9 7.1 
   
5.8 
12/22/13 10.862 15.7 7.2 92 241 18.9 1.6 15.0 7.0 4 2 0.6 5.9 
12/23/13 10.010 16.6 7.4 108 213 
 
1.6 15.8 7.0 4 3 
 
6.9 
12/24/13 10.027 16.2 7.4 132 225 
 
1.5 15.5 7.1 4 3 0.7 6.4 
12/25/13 9.362 16.0 7.5 92 232 
 
1.9 16.5 6.9 4 2 
 
5.4 
12/26/13 9.047 16.8 7.4 120 220 17.5 1.6 16.6 7.0 4 2 0.5 6.8 
12/27/13 8.980 17.2 7.3 
   
1.4 17.1 7.0 
   
6.9 
12/28/13 8.148 17.4 7.4 
   
1.3 17.2 7.0 
   
6.8 
12/29/13 8.919 17.2 7.4 132 248 22.7 1.9 16.6 7.1 4 2 0.4 5.4 
12/30/13 9.221 15.8 7.4 108 220 
 
1.2 16.2 6.9 5 3 
 
6.0 
12/31/13 9.255 16.2 7.3 128 224 
 














Appendix B: CECs (and MRLs) Analyzed 
Compound MRL (ng/L) Compound MRL (ng/L) 
1,7-Dimethylxanthine 100 Iohexol 1000 
2,4-D 5 Iopromide 5 
4-nonylphenol 100 Isobutylparaben 5 
4-tert-Octylphenol 50 Isoproturon 100 
Acesulfame-K 200 Ketoprofen 5 
Acetaminophen 500 Ketorolac 5 
Albuterol 5 Lidocaine 5 
Amoxicillin (semi-quantitative) 200 Lincomycin 10 
Andorostenedione 5 Linuron 5 
Atenolol 5 Lopressor 20 
Atrazine 5 Meclofenamic Acid 5 
Azithromycin 20 Meprobamate 5 
Bendroflumethiazide 5 Metazachlor 5 
Bezafibrate 5 Methylparaben 20 
BPA 10 Metolachlor 5 
Bromacil 5 Naproxen 10 
Butalbital 5 Nifedipine 20 





Carbadox 5 Oxolinic acid 10 
Carbamazepine 5 Pentoxifylline 5 
Carisoprodol 5 Phenazone 5 
Chloramphenicol 100 Primidone 50 
Chloridazon 5 Progesterone 5 
Chlorotoluron 5 Propazine 5 
Cimetidine 5 Propylparaben 5 
Clofibric Acid 5 Quinoline 5 
Cotinine 10 Salicylic Acid 100 
Cyanazine 5 Simazine 5 
DACT 5 Sucralose 1000 
DEA 5 Sulfachloropyridazine 5 
DEET 100 Sulfadiazine 5 
Dehydronifedipine 5 Sulfadimethoxine 5 
DIA 5 Sulfamerazine 5 
Diazepam 5 Sulfamethazine 5 
Diclofenac 5 Sulfamethizole 5 
Dilantin 20 Sulfamethoxazole 50 
Diltiazem 5 Sulfathiazole 5 
171 
Diuron 5 TCEP 10 
Erythromycin 10 TCPP 100 
Estradiol 5 TDCPP 100 
Estriol 5 Testosterone 5 
Estrone (E1) 5 Theobromine 100 
17β-Estradiol (E2) 5 Theophylline 200 
Ethylparaben 20 Thiabendazole 5 
Flumeqine 10 Triclocarban 5 
Fluoxetine 10 Triclosan 10 
Gemfibrozil 50 Trimethoprim 50 


















Appendix C: Stoichiometry Matrix 
 
Description Units 
r1 aerobic growth of heterotrophs on soluble substrate with ammonia as N source gCOD/m3/d 
r2 anoxic growth of heterotrophs on soluble substrate with ammonia as N source gCOD/m3/d 
r3 aerobic growth of heterotrophs on soluble substrate with nitrate as N source gCOD/m3/d 
r4 anoxic growth of heterotrophs soluble substrate with nitrate as N source gCOD/m3/d 
r5 decay of heterotrophs gCOD/m3/d 
r6 hydrolysis of entrapped organics gCOD/m3/d 
r7 hydrolysis of entrapped organic nitrogen gCOD/m3/d 
r8 ammonification of soluble organic nitrogen gN/m3/d 
r9 growth of autotrophs gCOD/m3/d 
r10 decay of autotrophs gCOD/m3/d 
r11 biodegradation of E1 g/m3/d 
r12 adsorption of E1 g/m3 
r13 desorption of E1 g/m3/d 
r14 biodegradation of atenolol g/m3/d 
r15 adsorption of atenolol g/m3 
r16 desorption of atenolol g/m3/d 
r17 biodegradation of lopressor g/m3/d 
r18 adsorption of lopressor g/m3 
r19 desorption of lopressor g/m3/d 
r20 biodegradation of meprobamate g/m3/d 
r21 adsorption of meprobamate g/m3 
r22 desorption of meprobamate g/m3/d 
r23 biodegradation of triclosan g/m3/d 
r24 adsorption of triclosan g/m3 
r25 desorption of triclosan g/m3/d 
r26 biodegradation of gemfibrozil g/m3/d 
r27 adsorption of gemfibrozil g/m3 
r28 desorption of gemfibrozil g/m3/d 
r29 biodegradation of DEET g/m3/d 
r30 adsorption of DEET g/m3 
r31 desorption of DEET g/m3/d 
r32 biodegradation of caffeine g/m3/d 
r33 adsorption of caffeine g/m3 
r34 desorption of caffeine g/m3/d 
r35 biodegradation of theobromine g/m3/d 
r36 adsorption of theobromine g/m3 
r37 desorption of theobromine g/m3/d 
r38 biodegradation of sucralose g/m3/d 
r39 adsorption of sucralose g/m3 
r40 desorption of sucralose g/m3/d 
r41 biodegradation of acesulfame-K g/m3/d 
r42 adsorption of acesulfame-K g/m3 
r43 desorption of acesulfame-K g/m3/d 
r44 biodegradation of iopromide g/m3/d 
r45 adsorption of iopromide g/m3 
r46 desorption of iopromide g/m3/d 
r47 biodegradation of iohexol g/m3/d 
r48 adsorption of iohexol g/m3 
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r5 
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r44 
     
1   
r45 
     
   
r46 
     
   
r47 
     
1   
r48 
     
   
r49 
     




  so snh snd xnd sno snn 
r1 -(1-yh)/yh -ibhn 





-(1-yh)/(2.86*yh) (1 - yh)/(2.86*yh) 
r3 -(1-yh)/yh 




    
-ibhn -(1-yh)/(2.86*yh) (1 - yh)/(2.86*yh) 
r5 
   
ibhn - fuh*iuhn 
  
r6 








   





   
ibhn - fua*iuhn 
  
r11 
      
r12 
      
r13 
      
r14 
      
r15 
      
r16 
      
r17 
      
r18 
      
r19 
      
r20 
      
r21 
      
r22 
      
r23 
      
r24 
      
r25 
      
r26 
      
r27 
      
r28 
      
r29 
      
r30 
      
r31 
      
r32 
      
r33 
      
r34 
      
r35 
      
r36 
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r38 
      
r39 
      
r40 
      
r41 
      
r42 
      
r43 
      
r44 
      
r45 
      
r46 
      
r47 
      
r48 
      
r49 




  salk sza xza szb xzb szc xzc szd xzd 
r1 - ibhn/14. 
        
r2 (- ibhn/14.) + ((1 - yh)/(14*2.86*yh)) 
        
r3 - ibhn/14. 
        
r4 (- ibhn/14.) + ((1 - yh)/(14*2.86*yh)) 
        
r5 
         
r6 
         
r7 
         
r8 1/14. 
        
r9 (- ibhn/14.)  - 1./(ya*7) 
        
r10 












      
r14 
   
-1 
     
r15 
   
-1 1 
    
r16 
   
1 -1 
    
r17 
     
-1 
   
r18 












       
-1 1 
r22 
       
1 -1 
r23 
         
r24 
         
r25 
         
r26 
         
r27 
         
r28 
         
r29 
         
r30 
         
r31 
         
r32 
         
r33 
         
r34 
         
r35 
         
r36 
         
r37 
         
r38 
         
r39 
         
r40 
         
r41 
         
r42 
         
r43 
         
r44 
         
r45 
         
r46 
         
r47 
         
r48 
         
r49 




  sze xze szf xzf szg xzg szh xzh szi xzi 
r1 
          
r2 
          
r3 
          
r4 
          
r5 
          
r6 
          
r7 
          
r8 
          
r9 
          
r10 
          
r11 
          
r12 
          
r13 
          
r14 
          
r15 
          
r16 
          
r17 
          
r18 
          
r19 
          
r20 
          
r21 
          
r22 
          
r23 -1 
         
r24 -1 1 
        
r25 1 -1 
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-1 
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-1 
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r41 
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r43 
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r46 
          
r47 
          
r48 
          
r49 




  szj xzj szk xzk szl xzl szm xzm 
r1 
        
r2 
        
r3 
        
r4 
        
r5 
        
r6 
        
r7 
        
r8 
        
r9 
        
r10 
        
r11 
        
r12 
        
r13 
        
r14 
        
r15 
        
r16 
        
r17 
        
r18 
        
r19 
        
r20 
        
r21 
        
r22 
        
r23 
        
r24 
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r26 
        
r27 
        
r28 
        
r29 
        
r30 
        
r31 
        
r32 
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r34 
        
r35 
        
r36 
        
r37 
        
r38 -1 
       
r39 -1 1 
      
r40 1 -1 












    
r44 
    
-1 
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-1 1 
r49 





Appendix D: Kinetic Equations 
 
Description Kinetic Equation 
r1 
aerobic growth of heterotrophs on soluble 




anoxic growth of heterotrophs on soluble 




aerobic growth of heterotrophs on soluble 




anoxic growth of heterotrophs soluble 
substrate with nitrate as N source 
etag*muh*MssHET*inhibsoaxHET*inhibsnhHE
T*MsnoHET*salksatHET*xbh 
r5 decay of heterotrophs bh*xbh 
r6 hydrolysis of entrapped organics 
kh* (subsatHET)*(MsoHET + 
etah*inhibsoo2HET*MsnoHET)*xbh 
r7 hydrolysis of entrapped organic nitrogen r6*(xnd/(xs)) 
r8 ammonification of soluble organic nitrogen ka*snd*xbh 
r9 growth of autotrophs 
mua*MsnhGEN*MsnhNIT*MsoNIT*salksatAU
T*xba 
r10 decay of autotrophs ba*xba 
r11 biodegradation of E1 kbioE1*sza*xbh 
r12 adsorption of E1 
kdE1*sza*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi
+xu)/icv 
r13 desorption of E1 kdes*xza 
r14 biodegradation of atenolol kbioate*szb*xbh 
r15 adsorption of atenolol 
kdate*szb*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi
+xu)/icv 
r16 desorption of atenolol kdes*xzb 
r17 biodegradation of lopressor kbiolop*szc*xbh 
r18 adsorption of lopressor 
kdlop*szc*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi
+xu)/icv 
r19 desorption of lopressor kdes*xzc 
r20 biodegradation of meprobamate kbiomep*szd*xbh 
r21 adsorption of meprobamate 
kdmep*szd*(xs+xbh+xba+xsto+xbp+xbt+xgly+x
i+xu)/icv 
r22 desorption of meprobamate kdes*xzd 
r23 biodegradation of triclosan kbiotri*sze*xbh 
r24 adsorption of triclosan 
kdtri*sze*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi+
xu)/icv 
r25 desorption of triclosan kdes*xze 
r26 biodegradation of gemfibrozil kbiogem*szf*xbh 
r27 adsorption of gemfibrozil 
kdgem*szf*(xs+xbh+xba+xsto+xbp+xbt+xgly+x
i+xu)/icv 
r28 desorption of gemfibrozil kdes*xzf 
r29 biodegradation of DEET kbioDEET*szg*xbh 
r30 adsorption of DEET 
kdDEET*szg*(xs+xbh+xba+xsto+xbp+xbt+xgly
+xi+xu)/icv 
r31 desorption of DEET kdes*xzg 
r32 biodegradation of caffeine kbiocaf*szh*xbh 
r33 adsorption of caffeine 
kdcaf*szh*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi
+xu)/icv 
r34 desorption of caffeine kdes*xzh 
179 
 Description Kinetic Equation 
r35 biodegradation of theobromine kbiothe*szi*xbh 
r36 adsorption of theobromine 
kdthe*szi*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi
+xu)/icv 
r37 desorption of theobromine kdes*xzi 
r38 biodegradation of sucralose kbiosuc*szj*xbh 
r39 adsorption of sucralose 
kdsuc*szj*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi
+xu)/icv 
r40 desorption of sucralose kdes*xzj 
r41 biodegradation of acesulfame-K kbioace*szk*xbh 
r42 adsorption of acesulfame-K 
kdace*szk*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi
+xu)/icv 
r43 desorption of acesulfame-K kdes*xzk 
r44 biodegradation of iopromide kbioiop*szl*xbh 
r45 adsorption of iopromide 
kdiop*szl*(xs+xbh+xba+xsto+xbp+xbt+xgly+xi
+xu)/icv 
r46 desorption of iopromide kdes*xzl 
r47 biodegradation of iohexol kbioioh*szm*xbh 
r48 adsorption of iohexol 
kdioh*szm*(xs+xbh+xba+xsto+xbp+xbt+xgly+x
i+xu)/icv 



























Active Heterotrophic Biomass 
    
muh 
heterotrophic maximum specific 
growth rate  
3.2 1.072 1/d 
ksh 
readily biodegradable substrate half 
































bh heterotrophic decay rate 
 
0.62 1.029 1/d 





Active Autotrophic Biomass 
    
mua 
autotrophic maximum specific growth 
rate  
0.9 1.072 1/d 
kna 










ba autotrophic decay rate 
 
0.17 1.029 1/d 
kalka 
alkalinity half saturation coefficient 





    
kh maximum specific hydrolysis rate 
 
3 1.072 1/d 
kx 
slowly biodegradable substrate half 










    
ka ammonification rate 
 
0.08 1.072 m3/gCOD/d 
High Concentration Inhibition 
    
kxbh 



























Biodegradation Constants         
kbioE1 biodegradation of E1   0.162 1.072 m3/g/d 
kbioate biodegradation of atenolol   0.0042 1.072 m3/g/d 
kbiolop biodegradation of lopressor   
 
1.072 m3/g/d 
kbiomep biodegradation of meprobamate   0 1.072 m3/g/d 
kbiotri biodegradation of triclosan   0.0012 1.072 m3/g/d 
kbiogem biodegradation of gemfibrozil   0 1.072 m3/g/d 
kbioDEET biodegradation of DEET   0.0015 1.072 m3/g/d 
kbiocaf biodegradation of caffeine   0.04 1.072 m3/g/d 
kbiothe biodegradation of theobromine   0.038 1.072 m3/g/d 
kbiosuc biodegradation of sucralose   0.0000065 1.072 m3/g/d 
kbioace biodegradation of acesulfame-K   0.01 1.072 m3/g/d 
kbioiop biodegradation of iopromide   0.0075 1.072 m3/g/d 
kbioioh biodegradation of iohexol   0.0008 1.072 m3/g/d 
Adsorption Constants         
kdE1 adsorption of E1   0.00017 1.072 m3/g 
kdate adsorption of atenolol   0.0003 1.072 m3/g 
kdlop adsorption of lopressor   
 
1.072 m3/g 
kdmep adsorption of meprobamate   0.00079 1.072 m3/g 
kdtri adsorption of triclosan   0.001905 1.072 m3/g 
kdgem adsorption of gemfribrozil   0.0004 1.072 m3/g 
kdDEET adsorption of DEET   0.0001 1.072 m3/g 
kdcaf adsorption of caffeine   0.0002 1.072 m3/g 
kdthe adsorption of theobromine   0.0002 1.072 m3/g 
kdsuc adsorption of sucralose   0.00054 1.072 m3/g 
kdace adsorption of acesulfame-K   0.00017 1.072 m3/g 
kdiop adsorption of iopromide   0.000036 1.072 m3/g 
kdioh adsorption of iohexol   0 1.072 m3/g 
kdes desorption coefficient   0.1 1.072 1/d 
 
